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Abstract: Chronic obstructive pulmonary disease (COPD) and heart diseases are considered 
independent risk factors for mortality and major cardiopulmonary complications after surgery. 
Coronary artery disease, heart failure and COPD share common risk factors and are often 
encountered, - isolated or combined -, in many surgical candidates. Perioperative optimization 
of these high-risk patients deserves a thorough understanding of the patient cardiopulmonary 
diseases as well as the respiratory consequences of surgery and anesthesia.
In contrast with cardiac risk stratiﬁ  cation where the extent of heart disease largely inﬂ  uences 
postoperative cardiac outcome, surgical-related factors (ie, upper abdominal and intra-thoracic 
procedures, duration of anesthesia, presence of a nasogastric tube) largely dominate patient’s 
comorbidities as risk factors for postoperative pulmonary complications.
Although most COPD patients tolerate tracheal intubation under “smooth” anesthetic induc-
tion without serious adverse effects, regional anesthetic blockade and application of laryngeal 
masks or non-invasive positive pressure ventilation should be considered whenever possible, 
in order to provide optimal pain control and to prevent upper airway injuries as well as lung 
baro-volotrauma. Minimally-invasive procedures and modern multimodal analgesic regimen 
are helpful to minimize the surgical stress response, to speed up the physiological recovery 
process and to shorten the hospital stay. Reﬂ  ex-induced bronchoconstriction and hyperdynamic 
inﬂ  ation during mechanical ventilation could be prevented by using bronchodilating volatile 
anesthetics and adjusting the ventilatory settings with long expiration times. Intraoperatively, 
the depth of anesthesia, the circulatory volume and neuromuscular blockade should be assessed 
with modern physiological monitoring tools to titrate the administration of anesthetic agents, 
ﬂ  uids and myorelaxant drugs. The recovery of postoperative lung volume can be facilitated 
by patient’s education and empowerment, lung recruitment maneuvers, non-invasive pressure 
support ventilation and early ambulation.
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Introduction
COPD and cardiovascular disease in surgical patients
Nowadays, surgeons, anesthesiologists and chest physicians are coping with large 
numbers of high-risk respiratory patients as a consequence of prolonged life expectancy, 
increasing prevalence of COPD and greater needs for invasive diagnostic procedures 
and surgical interventions (Halbert et al 2006). The prevalence of COPD is even 
higher among surgical candidates compared with aged-matched population groups (eg, 
5%–10% of COPD patients in general surgery, 10%–12% in cardiac surgery and 40% 
in thoracic surgery vs. 5% of COPD patients in the general population) (McAlister 
et al 2003; Halbert et al 2006; Licker et al 2006). As common risk factors (ie, smok-
ing, advanced age and sedentarity) are shared by cardiac and pulmonary diseases, a 
large proportion of COPD patients are afﬂ  icted with hypertension (34%), occlusive or 
aneurismal arterial disease (12%), heart failure (5%), cardiac arrhythmia or conduction 
blockade (12%) and ischemic heart disease (11%) (Sin et al 2005).International Journal of COPD 2007:2(4) 494
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Although mortality directly attributable to anesthesia is 
very low – probably around 1 in every 250,000 anesthetics – 
the operative mortality risk averages 0.5%–1%, being mainly 
attributed to myocardial infarct and heart failure, the leading 
causes of death in Western countries (Ergin et al 2004). Not 
surprisingly, patients with pre-existing organ dysfunction 
(eg, ischemic heart disease, COPD and renal insufﬁ  ciency) 
are more likely to develop an acute coronary syndrome, heart 
failure, bronchopneumonia or respiratory failure following 
major interventions (Kaafarani et al 2004).
In the past decades, the attention of health care providers 
was mainly focused on cardiovascular ischemic events and 
the importance of postoperative pulmonary complications 
(PPCs) has been largely underestimated. More recent pro-
spective cohort studies have highlighted that the incidence 
of respiratory failure (1%–3%) and bronchopneumonia 
(1%–5%) after noncardiac surgery was similar to the inci-
dence of major cardiovascular complications (cardiac failure, 
1%–2%; myocardial infarction, 0%–6%) (Fleischmann et al 
2003). In addition to the short- and long term death toll, these 
major cardiac and pulmonary complications implicate an 
enormous economic burden as a result of patient’s admis-
sion to intensive care units (ICU), prolonged hospital stay 
and use of expensive therapeutic treatment (Schweizer et al 
2002; Fleischmann et al 2003). Not infrequently, cardiac 
and pulmonary complications concur in the same surgical 
patients. For instance, severe intra-operative bleeding directly 
increases the risk of myocardial ischemia/infarct, ventilator-
induced pneumonia, sepsis and transfusion-related acute 
lung injury (ALI).
How to deﬁ  ne postoperative pulmonary 
complications (PPC)
As a prerequisite for perioperative risk assessment, clinicians 
and scientists should clearly deﬁ  ne meaningful criteria of 
speciﬁ  c disease conditions and surgical outcome endpoints. In 
the medical literature, the wide range in the incidence of PPCs 
(from 3% up to 80%) reﬂ  ects heterogenous population groups, 
inconsistent diagnostic/outcome deﬁ  nitions and incomplete 
data derived from retrospective studies (Fisher et al 2002). 
Although the development of respiratory dysfunction may 
forecast signiﬁ  cant PPCs, it may also reﬂ  ect the “natural” 
postoperative recovery processes. Transient and self-limiting 
impairment in spirometric values, respiratory muscle strength 
and gas exchange should be considered as part of the physi-
ological responses to surgery. For instance, most patients 
undergoing cardiothoracic or abdominal operations present 
some degree of hypoxemia and diffuse micro-atelectasis that 
will barely impact on the postoperative clinical course. In 
contrast, pleural effusions, sustained bronchospasm or fever, 
lobar atelectasis or hypoxemia non-responsive to supplemen-
tal oxygen may forecast more serious adverse events like 
bronchopleural ﬁ  stula, bronchopneumonia, ALI or respiratory 
failure requiring urgent medical interventions.
In an effort to standardize the reporting of adverse peri-
operative events, a group from the University Hospital of 
Zurich has validated a 5-grade scoring system based on the 
therapeutic consequences and residual disabilities in relation 
to surgical operations (Dindo et al 2004). Instead of taking into 
account biased surrogate items such as the length of hospital 
stay, the new scoring system ranks the severity of postopera-
tive complications by assessing organ dysfunction, long-term 
disabilities as well as the incremental need for pharmacologic 
treatment or other supportive/corrective interventions (phys-
iotherapy, endoscopy, drainage, re-interventions) (Table 1). 
Grade I complication entails any deviation from the normal 
postoperative course with no need for medical interventions, 
except antiemetics, antipyretics, analgesics, electrolytes, 
diuretics. Grades II and III involve complications requiring 
pharmacological treatment, blood transfusions or endoscopic, 
surgical or radiological interventions. Grade IV includes life-
threatening complications as well as single or multiple organ 
failure requiring ICU admission. Ultimately, perioperative 
death corresponds to a grade V. Availability of these objec-
tive and detailed outcome data is helpful to qualify hospital’s 
and physician’s performances and to improve quality of care 
allowing cost-efﬁ  cient assessment of health care interventions 
and human resources (Bruce et al 2001).
Understanding the physiological response to surgical 
insults, identiﬁ  cation of mortality/morbidity risk factors and 
gaining control over health care processes are the preliminary 
steps before testing and implementing medical interventions 
aimed to improve postoperative outcome. In this review, we 
will ﬁ  rst discuss the risk factors of postoperative cardiopul-
monary complications, then we will describe the respiratory 
consequences of surgery and anesthesia; ﬁ  nally, we will 
propose guidelines for optimizing perioperative medical care 
in COPD patients.
Risk factors for postoperative 
mortality and cardiopulmonary 
morbidity
Risk stratiﬁ  cation
Along with major advances in surgical and anesthetic man-
agement, the operative mortality and morbidity rates have International Journal of COPD 2007:2(4) 495
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Table 1 Grading of postoperative cardiopulmonary complications
  Diagnostic criteria  Grade I  Grade II  Grade III  Grade IV 
Cardiac        
 – Arrythmia  ECG, treatment with  SVE, benign VE, sinus  + pharmacological  tachyarrhythmia +  cardiac arrest + 
  electrolytes, drugs  tachycardia, AF +  treatment  electrical shock  deﬁ  brillation
  and/or electrical shock  electrolytes  (anti-arrhythmic)    and/or 
   adjustment      resuscitative 
         maneuvers 
 – Conduction  ECG, treatment with   AV 1st–2nd degree   AV 2nd degree block  AV 3rd degree block + 
 blockade  pacemaker block  (Wenckeback)  pacemaker 
 – Cardiac  Chest X-rays, drugs,  asymptomatic  + diuretics,   + transfer in HDU or  low cardiac output 
 insufﬁ  ciency echocardiography,    vasodilators  ICU,inotropes syndrome,  aortic 
  ICU/HDU transfer,         balloon 
 assist  device        counterpulsation
        
 – Tamponnade  echocardiography,      pericardial drainage  low cardiac output 
 drainage        and  drainage 
 – Myocardial  ECG, troponin  Transient ECG changes:  Troponin 0.1–1.5 ng/ml  Troponin   1.5 ng  Troponin   1.5 ng, 
 ischemia/infarct    ST-segment, T wave      unstable angina, 
         arrhythmias,  low
         cardiac  output
Pulmonary 
 – Atelectasis  Chest-X rays, CT-scan,  + chest physiotherapy  + CPAP  + bronchial ﬁ  broscopy 
 treatment       
 – Bronchopneumonia  Temperature,     + antibiotics,   + antibiotics and  + respiratory 
  WBC count,bacteriology,    on the ward  supportive respiratory  failure
 treatment      treatment
 – Hypoxemia  SpO2, PaO2, A-aDO2,  + oxygen therapy  + oxygen therapy  PaO2/FIO2   PaO2/FIO2   220 + 
 PaO2/FIO2, chest X-rays        220 + NIV ALI/ARDS  intubation,
 treatment        mechanical  ventila
         tion,  ALI/ARDS
 – Respiratory failure  Need for ventilatory      + NIV  intubation, 
 support        mechanical
         ventilation 
 – Bronchopleural  bronchoscopy, treatment    + endoscopic treatment  + surgical closure, 
  ﬁ  stula       empyema 
 – Pleural effusion  chest X-rays, drainage  mild  + thoracic drainage   
Abbreviations: SVE, supraventricular extrasystole; VE, ventricular extrasystole; AF, atrial ﬁ  brillation; AV, atrioventricular; HDU, high dependency unit; ICU, intensive care unit; 
ALI, acute lung injury; ARDS, adult respiratory distress syndrome.
Adapted from Dindo D, Clavien PA. 2004.
been considerably lowered over the past 20 years (Bonnet 
and Marret 2005). For instance, after lung resection and 
aortic abdominal reconstruction, operative mortality has 
dropped from 10% in the eighties to the current rates of less 
than 3% in most reference hospital centers (Spiliopoulos and 
de Perrot 2000; Licker et al 2002). In such context, patient- 
and procedure-related risk factors need to be thoroughly 
re-evaluated concerning their impact on postoperative cardiac 
and pulmonary outcomes.
Cardiac risk stratiﬁ  cation
In 1999, Lee et al (1999) analyzed a comprehensive large-scale 
surgical database and identiﬁ  ed 5 independent risk factors for 
major postoperative cardiac complications: (1) evidence for 
coronary artery disease, (2) history of cerebrovascular disease 
(stroke, ischemic attack), (3) moderate-to-severe renal insufﬁ  -
ciency (serum creatinine greater than 180 mm/L), (4) diabetes 
mellitus, and (5) high-risk surgery (chest, abdominal, vascu-
lar). After validation in further prospective studies (Boersma 
et al 2005), these ﬁ  ve items have been incorporated in a 
Revised Cardiac Risk Index (RCRI) which has been endorsed 
by the American College of Cardiology and American Heart 
Association (ACC/AHA) (Fleisher et al 2006). Noteworthy, 
patients presenting with one or more of these risk factors 
(RCRI), particularly those with limited exercise capacity 
(less than 4 MET; 1 MET = basal metabolic rate) and those 
undergoing major surgical procedure should be considered 
for preoperative non-invasive testing in order to exclude poor International Journal of COPD 2007:2(4) 496
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ventricular function, valvular dysfunction or silent coronary 
artery disease. Ultimately, preoperative clinical assessment 
(RCRI) and cardiac testing (thallium scintigraphy, echocar-
diography, stress test) are most useful to identify patients with 
ischemic heart diseases who might beneﬁ  t from preoperative 
revascularization and perioperative cardiac protective tech-
niques (ie, beta-blockers, anti-platelets, statines) (Fleisher 
et al 2006).
Recent data indicate that the risk-adjusted mortality fol-
lowing noncardiac surgery is much higher in patients with 
aortic stenosis (10%–28%), or heart failure (11.7%) than 
among those with coronary artery disease (6.6%) (Hernandez 
et al 2004; Kertai et al 2004; Zahid et al 2005). When the 
aortic valvular surface area is less than 0.5 cm2/m2 body 
surface area, valvular prosthetic replacement should be 
planned before elective noncardiac surgery or alternate non-
surgical options should be considered. Chronic heart failure 
is chieﬂ  y the end stage of most hypertensive, coronary and 
valvular diseases. Because of the aging population and the 
prolongation of the lives with modern therapies, the burden 
of these cardiovascular diseases is also growing among 
COPD patients. In adults older than 65 years, 2 to 9% suffer 
from aortic valve stenosis and the prevalence of congestive 
heart failure lies within 8%–12% (Christ et al 2005; Zahid 
et al 2005).
Pulmonary risk factors
In two prospective studies, a group of Canadian pneu-
mologists have questioned whether preoperative clinical 
assessment, pulmonary functional testing and intraoperative 
interventions could predict the occurrence of PPCs, namely 
pneumonia, atelectasis, respiratory failure, pneumothorax 
and pleural effusion (McAlister et al 2003; McAlister et al 
2005). The anesthesiologists referred only 8% of surgical 
candidates to a specialized consultation and the PPCs were 
best predicted by the following markers: advanced age 
(  65years, Odds Ratio [OR] 5.9), a positive cough test 
(OR 3.8), smoking  40 pack-years (OR 1.9), the presence of 
a nasogastric tube (OR 7.7) and anesthesia duration exceed-
ing 2.5 hours (OR 3.3). Major limitations of this study were 
related to the small population sample (N = 1,055 and 272 
patients, respectively), the low incidence of PPCs (2.8 and 
8%), the small proportion of major surgical procedures and 
the exclusion of high-risk patients, namely those with sleep 
apnea syndrome, neuromuscular disease and severe COPD 
requiring a planned admission to the ICU.
In 2001, the ﬁ  rst pulmonary risk indices for the occurrence 
of pneumonia and respiratory failure have been validated by 
analyzing two large cohorts including more than 160,000 
veterans undergoing noncardiac surgery (Arozullah et al 
2000, 2001). In analogy with the RCRI, these pulmonary risk 
scores were established by assigning points to several pre-
dictive factors for pneumonia (14 variables) and respiratory 
failure (12 variables) (Table 2). Overall, the major contribu-
tors to PPCs were related to an advanced age ( 70 yrs), the 
type of surgery (vascular, thoracic), the presence of COPD, 
renal failure or poor nutritional status as well as the occur-
rence of major intraoperative blood loss ( 4 units packed 
blood cells).
More recently, a systematic review including 145 studies 
(cohort, case-control, case-series and randomized controlled 
trials) of whom 27 reported multivariate analysis has pro-
vided further critical insight in preoperative pulmonary risk 
stratiﬁ  cation. The overall incidence of PPC was 6.8% (rang-
ing from 2% to 19%) (Smetana et al 2006). Not surprisingly, 
these clinical studies were heterogenous regarding their 
sample sizes (median 148 patients per group), study objec-
tives, deﬁ  nitions of PPCs and inclusion criteria. In contrast 
with cardiac risk stratiﬁ  cation where the extent of heart 
disease largely determined postoperative cardiac outcome, 
procedure-related factors largely dominated patient’s related 
comorbidities to predict PPCs. Peripheral and orthopedic 
procedures were considered at low-risk to develop PPCs 
whereas surgical interventions involving the thorax, the upper 
abdomen, as well as the head and neck regions, were more 
likely to interfere with respiratory function, particularly in 
the context of extended tissue trauma, large body ﬂ  uid shifts 
and multiple transfusion. Among patient-related predictors, 
the following items have been found to be independently 
associated with PPCs : 1) advanced age ( 70 yrs), 2) the 
American Society of Anesthesiologist (ASA) physical status 
classiﬁ  cation (classes  2), 3) a history of congestive heart 
failure, 4) the presence of COPD, 5) a poor general condition 
and 6) a low blood albumin level ( 35 g/L).
Speciﬁ  c risk factors for pulmonary 
complications
COPD
Exacerbation of bronchial inflammation with airway 
instrumentation, preoperative bacterial airway coloniza-
tion, surgery-induced immunosuppression and increased 
muscular work of breathing may all promote the onset of 
PPCs. Although results from small series have suggested an 
acceptable operative risk in COPD patients (Kroenke et al 
1992), the incidence of PPCs (except atelectasis) most often 
parallels the severity of respiratory impairment (moderate, International Journal of COPD 2007:2(4) 497
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Table 2 Multivariate risk indices for postoperative pneumonia, respiratory failure and cardiac complications
Variables  Odds ratio (95% CI)  Points for  Points for respiratory  Odds ratio (95% CI) for 
 for  PPC  pneumonia  failure  cardiac  complications 
Surgery type/site       
  AAA repair  6.9 (2.7–17.4)  15  27  2.8 (1.6–4.9)
  Thoracic  4.2 (2.9–6.2)  14  21  2.8 (1.6–4.9)
 Neurosurgery  2.5  (1.8–3.5)  8  14 
  Upper abdominal  2.9 (2.3–3.6)  10  14  2.8 (1.6–4.9)
  Vascular  2.2 (1.8–2.7)  3  14  2.8 (1.6–4.9)
  Head and neck  1.5 (1.3–1.7)  8  11 
Emergency surgery  2.2 (1.6–3.1)  3  11 
Prolonged surgery  2.3 (1.4–3.5)     
General anesthesia  1.8 (1.4–2.5)  4   
Transfusion   4 units    4   
Age 60–69  2.1 (1.6–2.6)     
Age 70–79  3.0 (2.1–4.4)  13  6 
Age   80    17  NA 
COPD 1.8  (1.4–2.2)  5  6 
Coronary artery disease    na  na  2.4 (1.3–4.2) 
History of cardiac failure  2.9 (1.0–8.0)  na  na  1.9 (1.1–3.5) 
History of stroke/TIA    4    3.2 (1.3–6.0) 
Renal insufﬁ   ciency  *   3  8 3.0  (1.4–6.8) 
ASA   3  2.6 (1.7–3.8)     
Functional dependency    10  7 
Weight loss   10%    7  na 
Altered sensorium    4   
Smoking ( 1 yr)  1.3 (1.0–1.6)  3   
Steroid treatment    3   
Alcohol ( 2 drinks)    2   
Albumin  3 g/dL  2.5  NA  9 
Risk class (total)    Risk for  Risk for 
Class 1    pneumonia  respiratory failure 
10–15 for pneumonia    0.24%   
 10 for resp. failure      0.50% 
Class 2      
16–25 for pneumonia    1.19%   
11–19 for resp. failure      2.10% 
Class 3      
26–40 for pneumonia    4.0%   
20–27 for resp. failure      5.3% 
Class 4      
41–55 for pneumonia    9.4%   
28–40 for resp. failure      11.9% 
Class 5      
 55 for pneumonia    15.8%   
 40 for resp. failure      30.9% 
*BUN  30 mg/dl (respiratory failure or pneumonia), creatinine  2 mg/dl (cardiac complications).
Abbreviations: AAA, aortic abdominal aneurysm; TIA, transient ischemic attack.
Adapted from Arozullah AM et al 2000, Arozullah AM et al 2001, Boersma E et al 2005, Lee TH et al 1999.
if FEV1 50%–80%; severe, if FEV1   50%), particularly in 
patients with abnormal clinical ﬁ  ndings (decreased breath 
sounds, wheezes, ronchi, prolonged expiration) and/or 
marked alterations of gas exchange (PaCO2  7 kPa, hypox-
emia requiring supplemental oxygen). The worst prognosis 
is expected in patients with pulmonary artery hypertension 
and chronically “fatigued” respiratory muscles given the 
risk of right ventricular failure with hemodynamic collapse 
and ventilator-dependency (Jaber et al 2005; Ramakrishna 
et al 2005).
In patients undergoing lung resection, a FEV1 below 60% 
has been shown to carry a two to threefold increased risk International Journal of COPD 2007:2(4) 498
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for operative mortality and major respiratory complications 
(Whalen F et al 2006). Besides the severity of COPD, the 
extent of lung resection, bronchial colonization and male 
sex have also been identiﬁ  ed as predictors of postoperative 
pneumonia (Licker, de Perrot et al 2003; Licker et al 2006; 
Schussler et al 2006; Tirumalasetty and Grammer 2006).
Asthma
Recent asthma symptoms, current use of anti-asthma drugs and 
history of tracheal intubation for asthma have all been associ-
ated with the development of PPCs. In contrast, other clinical 
studies have shown that patients with well-controlled asthmatic 
disease present similar risk for PPCs as those patients without 
asthma, regardless of the type of anesthesia (Tirumalasetty 
and Grammer 2006). In Warner’s study of over 1,500 asth-
matic patients, the PPC rates following general anesthesia and 
regional anesthesia were similar, refuting the empiric notion 
that regional anesthetic techniques were safer (Warner et al 
1996). Although infrequently associated with major PPCs, 
sustained or unrecognized bronchospasm induced by air-
way instrumentation may cause life-threatening hypoxemia 
whereas overzealous treatment with beta-adrenergic agonists 
may cause fatal ventricular arrhythmias. In the closed claim 
study of the American Society of Anesthesiologists, severe 
bronchospasm resulting in death or irreversible brain damage 
was implicated in 90% of cases charged because of severe 
intraoperative respiratory problems (Peterson et al 2005).
General anesthesia (GA)
General anesthetic agents, opiates, myorelaxants as well as 
mechanical ventilation are known to interfere with the respi-
ratory system. The combined effects of the supine position, 
GA and thoracic/abdominal incision produce an immediate 
decline in lung volumes with atelectasis formation in the 
most dependent parts of the lung (Hedenstierna and Edmark 
2005). Moreover, residual neuromuscular blockade persisting 
after anesthesia emergence has been incriminated in deﬁ  cient 
coughing, depressed hypoxic ventilatory drive and “silent” 
inhalation of gastric contents (Berg et al 1997).
General anesthesia exceeding 2.5–4 hours has been iden-
tiﬁ  ed as a strong predictor of PPCs (Arozullah et al 2000, 
2001). Indeed, prolonged exposure to general anesthetics 
alters the immune defenses and gas exchange capacity mainly 
by depressing the alveolar macrophage function, interfering 
with surfactant production, slowing of the muco-ciliary clear-
ance and increasing the permeability of the alveolar-capillary 
barrier. Other deleterious mechanisms involve the enhanced 
sensitivity of the pulmonary vasculature to neurohumoral 
mediators, activation of the alveolar nitric-oxide synthase 
and enhanced release of pro-inﬂ  ammatory cytokines.
Upper airway instrumentation (eg, tracheal intubation) 
and inhalation of irritants (eg, desﬂ  urane, external disin-
fectants) may trigger vagally-mediated reﬂ  ex bronchocon-
striction thereby promoting the expiratory collapse of the 
peripheral airways with incomplete lung alveolar emptying 
(Berry et al 1999; Goff et al 2000).
Obstructive apnea syndrome (OAS)
A preoperative history of snoring, apnea during sleep and 
abnormalities of the oropharynx (large tonsils, retrognathia, 
maxillary hypoplasia) are strongly evocative of an OAS, 
particularly in obese subjects where difﬁ  culties with airway 
instrumentation should be anticipated (den Herder et al 2004). 
Even very low concentrations of anesthetics, sedatives and 
opiates may trigger or worsen OSA by decreasing pharyn-
geal muscle tone and blunting the ventilatory and arousal 
responses to hypercarbia and upper airway obstruction. 
Given their higher prevalence of hypertension, arrhythmias, 
congestive (right) heart failure and coronary artery disease, 
patients with OAS are more susceptible to develop postop-
erative cardiac and cerebral ischemic damages.
Age
After adjustment for concomitant systemic illnesses, advanced 
age ( 70 years) remains an independent predictor of operative 
mortality, PPCs and cardiac morbidity (Polanczyk et al 2001). 
The loss of physiological organ reserve and “silent” organ dys-
function make the elderly prone to develop cardiopulmonary 
and cerebrovascular complications when facing surgical or 
traumatic insults. For instance, the airway closing capacity 
increases with age as does the perfusion in lung units with 
low ventilation/perfusion ratios (VA/Q) that result in increas-
ing venous admixture and, in turn deterioration in blood 
oxygenation (Hedenstierna and Edmark 2005). Surprisingly, 
atelectasis formation is independent of age, with children and 
teenagers showing as much atelectasis as elderly patients 
(Gunnarsson, Tokics, Gustavsson et al 1991).
Obesity
Premature collapse of peripheral airways is most likely to 
occur in obese patients because of the restrictive ventilatory 
pattern and the elevated closing airway capacity (von Ungern-
Sternberg et al 2004). Although the reduction in functional 
reserve capacity (FRC) facilitates the formation of atelectasis 
and aggravates postoperative hypoxemia, clinical investi-
gations have failed to document any association between 
mild-to-moderate obesity and severe PPCs, except among the International Journal of COPD 2007:2(4) 499
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subset of patients with OSA. A body mass index exceeding 
40 kg/m2 also conveys a higher risk for PPCs. In these mor-
bidly obese patients, the likelihood to develop atelectasis or 
pneumonia after abdominal surgery was found to be close 
to 30% with an adjusted odds ratio of 2.8 (95% conﬁ  dence 
interval 1.7–4.8) compared with non-obese patients (von 
Ungern-Sternberg et al 2004). Besides functional pulmonary 
impairment, a greater propensity to develop postoperative 
wound infection and thromboembolic events has been con-
sistently demonstrated in overweight patients.
General status and physical ﬁ  tness
The 5 grade American Society of Anesthesiology (ASA) 
classiﬁ  cation is applied worldwide by all anesthesiologists. 
This physical status scoring system was originally designed 
to estimate the risk of operative mortality. Subsequently, a 
number of studies have extended its use to predict postop-
erative outcome. Patients belonging to ASA classes 3 and 4 
being at higher risk for cardiopulmonary complications than 
ASA 1 and 2 patients (Table 3) (Wolters et al 1996).
Similarly, simple information from the patient’s history 
and clinical examination such as an altered sensorium, the 
inability to climb at least two ﬂ  ights of stairs and functional 
dependency (ie, need for assistance in daily life activities) 
have been shown to be predictive of major postopera-
tive cardiopulmonary complications. More sophisticated 
physiological assessment such as the determination of the 
anaerobic threshold during exercise (maximal oxygen 
consumption, VO2 max) and the six minutes walking test 
also provides valuable prognostic information in borderline 
patients (Win et al 2005). Before lung resection, a VO2 max 
less than 15 ml/kg/min, a walking distance less than 300 m 
over 6 minutes or the inability to climb at least four ﬂ  ights 
of stairs are better predictors than spirometric variables to 
discriminate those patients who will, or will not, develop 
cardiopulmonary complications. Diminished cardiac and 
pulmonary physiological reserves should be differentiated 
from muscular deconditioning due to chronic debilitating 
illnesses as possible causes of reduced aerobic exercise 
capacity.
Smoking
Cigarette-smoke contains more than 1,000 components 
with wide-ranging effects on pulmonary, cardiovascular 
and immune functions, healing of wounds, hemostasis, drug 
metabolism and patient mental status, all of which may inﬂ  u-
ence the postoperative outcome (Moller et al 2002; Warner 
2006). Smoking status is a consistent univariate risk factor 
for adverse cardiac events and a variety of pulmonary adverse 
events such as bronchospasm, laryngospasm, cough and 
hypoxemia requiring ICU admission. In observational stud-
ies using multivariate analysis, current smoking ( 20 units 
pack year) has been identiﬁ  ed as a modest risk factor for 
serious PPCs (OR 1.26 with 95% CI, 1.01–1.56) and tissue-
healing problems but not for cardiac complications, although 
smoking behavior obviously inﬂ  uences the progression of 
vascular atheromatosis and long-term survival (Smetana et al 
2006). Not only active smoking but also passive exposure to 
smoking in children and adults have been found to increase 
the risk of intra- and postoperative respiratory problems and 
to prolong the effects of neuromuscular blocking agents 
(Drongowski et al 2003; Reisli et al 2004).
Several mechanisms render smokers more suscep-
tible to develop PPCs: excessive production of mucus, 
increased sensitivity of upper airway reﬂ  exes, slowed 
bronchial mucus clearance, alteration in surfactant syn-
thesis, increase in pulmonary epithelial permeability as 
well as impaired macrophage and natural killer cytotoxic 
Table 3 General health status assessment
Variables  Class I  Class II  Class III  Class IV  Class V 
ASA  Normal healthy,  Controlled medical  Medical condition  Poorly controlled-medical  Moribund,
  without organic  condition without  with systemic effects  condition  expected to
  physiologic, or  systemic effects  and/or functional  potentially life-  survive less
  psychiatric disorders  (smoking without  compromise (stable  threatening (eg,  than 24 hr post-
    COPD, anemia,  angina or heart  unstable angina,  operatively
    70 years  failure, moderate  severe COPD)
     BPCO)   
Duke   8 MET  5–7 MET  2–4 MET   2 MET 
Activity  run, swim,  yardwork, climb  Light housework,  walking 1–2 blocks,
Status play  tennis  4  ﬂ  ights of stairs   3 ﬂ  ights of stairs  climb 1–2 ﬂ  ights of
Index      stairs,  bedbound
Abbreviation: MET, metabolic equivalent (1 MET = basal oxygen cons umption).International Journal of COPD 2007:2(4) 500
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activity. The number of pack-year cigarettes/cigars and 
the timing of smoking cessation may inﬂ  uence both the 
sensitivity and the reactivity of the tracheobronchial tree, 
mucociliary transport as well as the occurrence of PPCs 
(Warner et al 1989). Actually, impaired wound/bone heal-
ing, susceptibility to bacterial infections and dehiscence of 
vascular/bowel anastomosis may result from the limited 
availability of oxygen within healing tissues along with 
the anti-proliferative effects of nicotine on red blood cells, 
ﬁ  broblasts and macrophages.
Interestingly, the dose-requirements for anesthetic induc-
tion and postoperative opiate analgesia are slightly higher in 
smokers compared with non-smokers whereas the incidence 
for nausea and vomiting is surprisingly lower (Creekmore 
et al 2004; Lysakowski et al 2006; Whalen F et al 2006). 
Although increased baseline stress is often reported among 
smokers, changes in perceived stress over the perioperative 
period and acute withdrawal symptoms are unrelated to the 
current smoking status (Warner et al 2004; Warner 2006).
Alcohol
A two-fold increased risk of ALI has been observed among 
heavy alcohol consumers (more than 60 g of ethanol per day) 
admitted to the medical ICU and those undergoing lung resec-
tion, compared with alcohol-free patients (Licker, de Perrot 
et al 2003). Experimental data indicate that ethanol causes 
depletion of pulmonary antioxidant glutathione which in turn 
leads to decreased surfactant production, impaired alveolar 
liquid clearance and alterations in epithelial cell permeability 
(Burnham et al 2004). Moreover, chronic alcoholics have a 
greater vulnerability to postoperative bleeding and infec-
tious complications consequent to impaired immune status 
(eg, suppression of interleukin-6 to interleukin-10 ratio), 
nutritional deﬁ  cits and bronchoaspiration in the context of 
autonomic neural dysfunction and alcohol withdrawal syn-
drome (Paull et al 2004).
Respiratory consequences
of anesthesia and surgery
Anesthetic techniques and respiratory 
function
Respiratory mechanics and general anesthesia
In awake supine subjects, contraction of the inspiratory 
muscles causes lung expansion along with a downward shift 
of the diaphragm whereas during passive expiration, the 
dome-shaped diaphragm moves cranially as a result of the 
elastic lung recoil and the relaxation of the inspiratory mus-
cles; the hydrostatic pressure gradient due to the abdominal 
content and the eventual active contraction of the expiratory 
abdominal wall muscles may further displace the diaphragm 
in cranial direction (Figure 1). Following anesthesia induc-
tion – with or without muscular paralysis – all respiratory 
muscles being relaxed, there is a fall in the functional reserve 
capacity (FRC) with a consistent cephalad shift of the de-
pendent part of the diaphragm while the nondependent dia-
phragmatic part moves slightly downwards or remains static 
(Warner 2002). With mechanical ventilation, the positive 
transpulmonary pressure causes the greatest displacement of 
the nondependent part, although with large tidal volume, all 
parts of the diaphragm move equally (“piston-like” motion). 
These anesthetic-induced changes in diaphragmatic motion 
have been observed in healthy subjects as well as in COPD 
patients (Gunnarsson, Tokics, Lundquist et al 1991).
As demonstrated by chest imaging techniques, atelec-
tatic areas develop in almost 90% of anesthetized patients, 
involving as much as 5%–20% of the total lung volume, pre-
dominantly in its dependent parts (Hedenstierna and Edmark 
2005). By changing the position from upright to supine in 
healthy adults, the FRC is reduced by 0.8–1.0 L and there is a 
further decrease by 0.4–0.5 L after the induction of anesthe-
sia. The reduction in FRC (from 3.5 to 2 L, near the residual 
volume) corresponds to the formation of atelectasis and low 
ventilation-perfusion areas (Figure 1) that in turn reduce the 
compliance of the respiratory system (from a mean of 95 to 
60 ml/cm H2O). Not surprisingly, the size of the atelectatic 
areas correlates with the decrease in FRC and the fall in 
arterial oxygen saturation (Lindberg et al 1992).
Some of the collapsed areas persist in the postoperative 
period and are compounded by limited respiratory motion due 
to insufﬁ  cient pain control, injuries of respiratory muscles 
and/or diaphragmatic dysfunction after manipulation of 
abdominal viscera or intra-thoracic interventions. Increased 
“stiffness” of the thoracic/abdominal compartments and 
increased airway resistance due to lower lung volumes both 
contribute to increase the work of breathing after major surgi-
cal procedures (Hedenstierna and Edmark 2005).
General anesthetic agents
General anesthetic agents modulate the respiratory function 
at 3 key levels: (1) the central medullary command and the 
neural reﬂ  ex ventilatory pathways, (2) the airways involv-
ing muscular tone and muco-ciliary clearance, and (3) the 
hypoxic pulmonary vasoconstriction (HPV) which controls 
the distribution of blood ﬂ  ow versus ventilation (Table 4). 
Of note, the anesthetic-induced impairment in respiratory 
function is only transient and the breathing pattern completely International Journal of COPD 2007:2(4) 501
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normalizes within 2 to 6 hours after anesthesia emergence 
in volunteers and following peripheral or lower abdominal 
procedures.
Opiates, benzodiazepines and anesthetic agents attenuate 
the central and peripheral chemosensitive reﬂ  exes with a 
consequent dose-dependent depression of the hypoxic and 
hypercapnic ventilatory responses (van den Elsen et al 1995, 
1998; Dahan et al 2004). Few sedative drugs are devoid of 
central respiratory depressive effects: droperidol potentiates 
the hypoxic ventilatory response by blocking the action 
of endogenously released dopamine and the histamine-
antagonist, diphenhydramine, counteracts the alfentanil-
induced decrease in the slope of the CO2 ventilatory response 
(Babenco et al 1998). None of the intravenous agents are 
thought to interfere with bronchial smooth muscle tone 
neither with the HPV response.
In contrast, volatile anesthetic agents (halothane, isoﬂ  u-
rane, desﬂ  urane, sevoﬂ  urane) are known to relax directly 
bronchial and vascular smooth muscles (Rooke et al 1997). 
In isolated lung preparations with lobar atelectasis or hypoxic 
ventilation, volatile anesthetics given at twice the mini-
mum alveolar concentration (2 MAC) have been shown to 
decrease the HPV response by 50% if the pulmonary ﬂ  ow was 
maintained constant. In these experimental conditions, redis-
tribution of pulmonary blood ﬂ  ow towards poorly oxygenated 
regions contributes to widen the alveolar-arterial oxygen 
gradient (PA-aO2) and to cause arterial oxygen desaturation 
by increasing intra-pulmonary shunting (Moudgil et al 2005). 
In clinical practice, only mild impairment in blood gas ex-
change is observed under lower concentrations of inhalational 
anesthetics (1–1.5 MAC), because the direct anesthetic-in-
duced inhibition of the HPV response is partially opposed 
by the reduced mixed venous oxygen pressure consequent 
to the anesthetic-induced myocardial depression.
Myorelaxants
As already mentioned, residual neuromuscular blockade is an 
independent predictor of PPCs and has been incriminated in 
alveolar hypoventilation and silent gastric regurgitation with 
bronchoaspiration. Indeed, mild blockade of the muscarinic 
receptors with myorelaxants has been shown to attenuate the 
ventilatory response to hypoxia and to impair the contracting 
capacity of the pharyngo-laryngeal muscles, thereby interfer-
ing with the control of the upper airways (Eikermann et al 
FRC
2 1 End-Expiration
End-Inspiration 1
2
3. Elastic Wall recoil (passive)
4. Abdominal forces (viscera, muscle contraction/tone)
4
3
2. or mechanical ventilation (small arrows)
1. Contraction of inspiratory muscles
2. Abdominal forces (viscera, muscle contraction; large arrow)
1. Elastic lung recoil(passive, small arrows)
Figure 1 Thoracic wall and diaphragmatic motion during breathing in awake (dotted line) and in anesthetized subjects (continuous line).International Journal of COPD 2007:2(4) 502
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2006). In addition, volatile anesthetic agents and several 
pharmacologic agents (eg, magnesium, aminoglycosides) 
are known to enhance the effects of myorelaxants at the 
neuromuscular endplate by lowering the neural release 
of acetylcholine, inducing conformational change within 
the cholinergic receptor and/or by altering intra-muscular 
signaling (Eriksson 1994). Moreover, prolonged neuro-
muscular blockade should be anticipated in patients with 
defective metabolic clearance pathways (hepatic or renal 
insufﬁ  ciency) and those with neuromuscular disorders (ie, 
myasthenia, deconditioning, Guillain-Barre syndrome), 
particularly if long acting myorelaxants are repeatedly or 
continuously administered.
Regional anesthesia
Spinal and epidural anesthesia at the lumbar level have no 
signiﬁ  cant effects on respiratory function, except in morbidly 
obese patients where the neuraxial blockade has been shown 
to produce a 20%–25% fall in expiratory functional volume 
(FEV1, FVC) that may interfere with the ability to cough 
and to clear bronchial secretions as a result of blocking the 
abdominal wall muscles (Regli et al 2006).
With thoracic epidural analgesia (TEA) using high 
concentrations of local anesthetics (lidocaine 2%, bupivacaine 
0.5%), paralysis of the intercostal and abdominal wall muscles 
are responsible for a –10% to –20% decrease in inspiratory 
and expiratory capacity without affecting the HPV, the bron-
chial smooth muscle tone and the ventilatory response to 
hypoxia and hypercarbia (Groeben et al 1994; Sakura et al 
1996). Diaphragmatic function remains unimpeded as far as 
the neuraxial blockade remains below the cervical emergence 
of phrenic nerves (C3–C5). In addition to blocking the noci-
ceptive afferences, TEA directly suppresses the sympathetic 
efferent neural outﬂ  ow (from C8 to T4), it reduces by 20% the 
hypnotic requirements and confers cardiac protective effects by 
augmenting coronary blood ﬂ  ow, lowering myocardial oxygen 
consumption, attenuating platelet hyperaggregability and rais-
ing the arrhythmic ventricular and atrial thresholds (Groban 
et al 1999; Hodgson and Liu 2001; Licker, Spiliopoulos et al 
2003; Liu et al 2004).
Regarding peripheral nerve blockade, the supraclavicular 
techniques (ie, interscalene anesthetic block) are contraindi-
cated in patients with severe pulmonary disease since paralysis 
of the ipsilateral hemidiaphragm occurs in 100% of cases 
with consequent limitations of lung volumes (mean –32% 
FEV1, –30% FVC) (Urmey and Gloeggler 1993). Preliminary 
studies suggest that the infraclavicular techniques – except 
the modiﬁ  ed Raj approach – also produce mild-to-moderate 
impairment in respiratory function (Rettig et al 2005).
Noteworthy, following systemic reabsorption or i.v. 
administration, local anesthetics exert direct central neural 
effects manifested by mild enhancement of the ventilatory 
drive and blunting of the nociceptive inputs.
Blood gas exchange
Despite the administration of 30%–40% oxygen in the 
inspired gas, the PA-aO2 gradient increases during general 
anesthesia, regardless of the type of anesthetic agent and 
the mode of ventilation (spontaneous or mechanically con-
trolled). Breathing of pure oxygen may even further increase 
PA-aO2 by promoting alveolar collapse in low VA/Q areas 
(Rothen et al 1995).
The increase in PA-aO2 has been mainly associated with 
increased venous admixture (“shunting” effect) as a result 
of atelectasis formation, greater mismatch in VA/Q units 
and attenuation of the HPV response (Rothen et al 1998). 
According to a three-compartment lung model, GA produces 
a “shrinkage” of the FRC: the lung compartment with normal 
VA/Q becomes smaller whereas the other two compartments 
become larger, one with atelectasis (“true shunt” effect) 
Table 4 Effects of anesthesia on respiratory function
1. Lung  volume
Atelectasis in dependent lung areas
Ë Functional respiratory capacity (FRC)
Ê Closing volume
Ë Lung compliance
In COPD patients: Ê FRC and Ê dead space (air trapping)
due to incomplete expiratory emptying of the most diseased
lung regions
2. Airways
Bronchodilatation (volatile anesthetic agents)
Ë Tonic activity of the muscle controlling the upper airways
Ë Bronchial muco-ciliary clearance
Ê = Airway resistance
3. Ventilatory  control
Ë Ventilatory response to hypercarbia
Ë Ventilatory response to hypoxia
Ë Ventilatory response to acidosis
4. Pulmonary  circulation
Ë Hypoxic vasoconstrictor response (volatile anesthetic agents)
5.  Blood gas exchange
Ê PA-aO2 gradient due to mismatch in regional VA/Q ratios
6. Immune  function
Ë Bactericidal activity of alveolar and bronchial macrophages
Ê Release of pro-inﬂ  ammatory cytokines
Abbreviations: PA-aO2 gradient, alveolar-arterial oxygen gradient;  VA/Q ratios, 
ventilation – perfusion ratios.International Journal of COPD 2007:2(4) 503
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and one with low VA/Q units (“shunt-like” effect) as a 
consequence of increasing airway closure (Hedenstierna 
and Edmark 2005).
On the second and third day following major surgery, 
recurrent nocturnal hypoxemic episodes have been attributed 
to sleep disturbances and abnormal breathing patterns that 
may be aggravated by the administration of analgesic and sed-
ative drugs (Rosenberg et al 1999). Besides abnormal ventila-
tory patterns, circulatory failure, sepsis and hypermetabolic 
conditions may also alter oxygen exchanges (Fleischmann 
et al 2003; Licker, de Perrot et al 2003). For instance, elevated 
capillary hydrostatic pressure due to acute heart failure and 
inflammatory damages of the alveolar-capillary barrier 
may produce interstitial lung edema and alveolar ﬂ  oading 
resulting in poor oxygen diffusion capacity.
Anesthetic and analgesic techniques
in COPD patients
In patients with bronchospastic disease, the bronchodilating 
effects of volatile anesthetics are associated with improved 
ventilatory mechanics which outweighs the partial inhibition 
of the HPV and the consequent increase in intra-pulmonary 
shunting (Volta et al 2005).
Interestingly, perioperative impairment in gas exchange 
does not parallel the severity of pre-existent lung disease 
(Bardoczky et al 2000). Indeed, blood oxygenation is better 
maintained within the ﬁ  rst 10 minutes of one-lung ventilation 
in patients with end-staged COPD compared with healthy 
control subjects (Aschkenasy et al 2005). The lack of atel-
ectasis formation and preservation of FRC in COPD patients 
may be explained by three complementary mechanisms 
(Gunnarsson, Tokics, Lundquist et al 1991; Kleinman et al 
2002; Warner 2002): (1) chronic airﬂ  ow obstruction that 
generates intrinsic positive end-expiratory pressure (PEEPi), 
(2) loss of lung elastic recoil and the increased stiffness of 
the chest wall, (3) relaxation of the abdominal muscular tone 
(facilitated with analgesia) promoting caudal displacement 
of the diaphragm.
Postoperatively, the risk of respiratory insufﬁ  ciency 
requiring mechanical ventilation is mainly attributed to 
abnormal ventilatory control and/or muscular pump fail-
ure (Schweizer et al 2002; Licker, de Perrot et al 2003). 
A leaky alveolar-capillary barrier associated with sepsis or 
elevated pulmonary capillary pressure due to ﬂ  uid overload 
or heart failure represent alternative mechanisms of acute 
respiratory failure (Licker et al 2006). As a rule, most 
COPD patients exhibit weaker HPV and blunted ventilatory 
responses to CO2 and hypoxia. Flattening and shortening of 
the diaphragm represent mechanical disadvantages whereas 
the diaphragmatic pumping efﬁ  ciency may be impaired 
by deconditioning, insufﬁ  cient muscular O2 delivery and 
enhanced muscle catabolism as a result of bed rest, heart fail-
ure as well as the neuroendocrine and inﬂ  ammatory response 
to surgery. Nevertheless, the contractile efﬁ  ciency within the 
crural and costal parts of the diaphragm is partly maintained 
by length adaptation processes whereby chronically shortened 
muscular ﬁ  bers lose excess sarcomeres and with time, the 
remaining sarcomeres are restored to the optimal operating 
length, generating a virtual normal contraction (Gunnarsson, 
Tokics, Lundquist et al 1991; Gorman et al 2002).
In contrast with parenteral opiates and sedatives which 
may worsen OAS and ventilatory depression, TEA repre-
sents the ideal analgesic modality following thoracic and 
upper abdominal surgery. Given the differential sensitivity 
of motor and sensitive nerves to analgesics, TEA using low 
concentrations of local anesthetic agents and low doses of 
opiates effectively suppresses both the afferent nocicep-
tive inputs and the efferent sympathetic output while the 
respiratory muscular activity and the HPV response are well 
preserved. Importantly, in severe COPD patients, TEA has 
been shown to improve ventilatory mechanics resulting in 
decreased airway resistance, lower work of breathing and bet-
ter preservation of the inspiratory and expiratory capacities 
allowing lung recruitment maneuvers and voluntary drainage 
of bronchial secretions (Groeben, Schafer et al 2002).
Inﬂ  uence of major surgery on respiratory 
function
In contrast to lower abdominal, orthopedic and superﬁ  cial 
surgery, upper abdominal and intra-thoracic procedures 
produce marked alterations in respiratory function as 
evidenced by standard pulmonary functional tests, imaging 
techniques (ultrasound, radiology, CT-scanning) and various 
physiological measurements such as electromyography, body 
plethysmography as well as esophageal and gastric pressures 
(Pga, Pes) (Hedenstierna and Rothen 2000; Hedenstierna 
and Edmark 2005).
The pulmonary restrictive syndrome following thoracic 
and abdominal surgery is characterized by substantial 
reductions in lung volumes (–30% of FRC and total lung 
capacity, –40% to 60% of FEV1) with an elevated airway 
occlusion pressure and a shallow “thoracic” breathing 
pattern (Hedenstierna and Edmark 2005). These respiratory 
changes peak within the ﬁ  rst 24–48 h and normalize over the 
next 4–10 days. Typically, minute ventilation is maintained 
by increasing the respiratory rate at smaller tidal volumes International Journal of COPD 2007:2(4) 504
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whereas the reduction in muscular diaphragmatic activity 
is associated with the inspiratory expansion of the thorax 
instead of the normal abdominal excursion (Nimmo and 
Drummond 1996; Hedenstierna and Rothen 2000; Groeben, 
Schafer et al 2002). Following uncomplicated surgical 
cases, neural pathways and diaphragmatic muscles remain 
functionally intact as shown by the restoration of the trans-
diaphragmatic pressure swings when the phrenic nerves are 
electrically stimulated at the cervical level or when patients 
are simply asked to “take a deep breath”.
Overall, postoperative diaphragmatic dysfunction is 
attributed to 3 different mechanisms: direct phrenic nerve 
injuries, reﬂ  ex phrenic nerve inhibition and muscular pump 
failure.
Direct phrenic nerve injuries occur rather infrequently as 
a result of nerve elongation due to surgical retractors or neck 
malposition, surgical dissection, the application of cold-packs 
or the infusion of cold ﬂ  uids in the thoracic cavity (Licker 
et al 1997). In the case of postoperative acute respiratory 
distress, chest ultrasounds and ﬂ  uoroscopy are helpful to 
document an elevated hemidiaphragm with paradoxical 
upward motion during inspiration or the “snifﬁ  ng” test.
Reﬂ  ex inhibition of phrenic nerve output is directly 
linked to abdominal and thoracic manipulations that have 
been shown to activate afferent medullary pathways (Sprung 
et al 1992). Moreover, with the increasing central drive to 
breath, the increased intercostal muscular activity outweighs 
the diaphragmatic activity resulting in a decreased Pga/Pes 
ratio and in turn, a reduced diaphragmatic motion. Sustained 
tonic activity of the abdominal wall muscles which persists 
during the early phase of inspiration may further prevent 
caudal displacement of the diaphragm. Conversely, sudden 
relaxation of the abdominal muscles at the onset of inspiration 
has been shown to produce paradoxical abdominal motion 
in some COPD patients.
Finally, clinical studies comparing laparoscopic and 
traditional “open” surgical approaches lend support to the 
hypothesis that alterations of indices of diaphragmatic func-
tion paralleled the severity of surgical trauma leading to reﬂ  ex 
inhibition of phrenic nerve and inspiratory muscles activity. 
Not surprisingly, diaphragmatic function is less impaired and 
respiratory volumes are better preserved after minimally-
invasive surgical approaches given the lesser inﬂ  ammatory 
and neurohumoral responses (Ciofolo et al 1990; Hasukic 
et al 2002). Conversely, prolonged surgical stress and septic 
events activate the hypothalamic-pituitary-adrenal axis lead-
ing to progressive atrophy of respiratory muscles via the 
production of glucocorticoids and the release of cytokines, 
nitric oxide and oxygen-derived free radicals (Lanone et al 
2005). In these critically-ill patients, the fall in maximal 
diaphragmatic force over several days parallels the reduction 
in muscular mass as a result of oxidative myoﬁ  brillar inju-
ries, increased protease activity and downregulation of the 
insulin-like growth factor-I. In an attempt to limit this ongo-
ing wasting process, the release of beta-endorphin decreases 
the activation of respiratory muscles, by changing the pattern 
of breathing which becomes more rapid and shallow. In 
addition to the neurohumoral and inﬂ  ammatory interferences, 
sustained inspiratory overload may promote diaphragmatic 
muscular “fatigue” whereas electrolyte imbalance (hypo-
kalemia, hypophosphatemia, hypocalcemia), nutritional 
defects and circulatory failure may further compromise the 
contracting capacity of the respiratory muscles.
In contrast with parenteral opiates, blocking nociceptive 
and visceral neural afferences by central neuraxial anesthesia 
has been shown to reverse the abnormal breathing pattern 
(Pansard et al 1993; Vassilakopoulos et al 2000). Indeed, fol-
lowing abdominal surgery, provision of TEA is accompanied 
by slowing the respiratory rate, increasing tidal volume and 
restoration of diaphragmatic function (electromyographic 
activity and transdiaphragmatic pressure). Besides inter-
rupting the afferent inputs originating from the thorax and 
abdomen, TEA using high concentrations of local anesthet-
ics also blocks the efferent output reaching the abdominal 
expiratory muscles and intercostal muscles, thereby limit-
ing the ability to cough and to clear bronchial secretions 
(Polaner et al 1993). Moreover, it has been speculated that 
abdominal motor blockade would facilitate downward dia-
phragmatic displacement by suppressing the interference of 
sustained tonic abdominal muscular activity on the indices 
of diaphragmatic activity rather than by changing the real 
diaphragmatic activity.
Taken together, animal and clinical experiments support 
the concept that abdominal/thoracic manipulations activate 
afferent medullary pathways leading to a reﬂ  ex inhibition 
of the phrenic nerve output whereas inﬂ  ammatory media-
tors (eg, cytokines), oxygen free-radical and insufﬁ  cient O2 
delivery may directly impair the contractile capacity of the 
diaphragmatic myoﬁ  brilles.
Principles of perioperative 
anesthetic care
Among COPD patients undergoing major surgery, PPCs 
and cardiac complications are equally prevalent and clini-
cally important in terms of mortality/morbidity rates and 
hospital resource consumption. Care bundles, a package International Journal of COPD 2007:2(4) 505
COPD and surgery
of best evidence-based practices are being introduced into 
several areas of medicine to speed up the recovery process, 
shorten the hospital stay and alleviate the costs of health 
care interventions. The current medical knowledge supports 
the implementation of perioperative strategies aimed to 
reduce the risk of cardiac, pulmonary and infectious com-
plications (Table 5) (Buhre and Rossaint 2003; Lawrence 
et al 2006).
Preoperative consultation
Patients at risk of serious cardiac and respiratory complica-
tions can be identiﬁ  ed by combining information gathered 
from the clinical history (age, comorbidities, presenting 
disease) as well as the assessment of functional autonomy 
(social dependency, exercise tolerance) and the severity of 
the surgical stress. The anesthetic consultation is aimed to 
answer the following key questions: “Is the patient ﬁ  t for 
surgery? Is it possible to improve the patient’s condition? 
Are there alternate therapeutic modalities? What are the 
speciﬁ  c risk and beneﬁ  ts related to these surgical treatment 
options” (Anon 2002).
For cardiac risk stratiﬁ  cation, the preoperative workup is 
focused on screening the known predictors of cardiac com-
plications: severe aortic stenosis, severe heart failure, poor 
exercise tolerance ( 4 MET) as well as the ﬁ  ve items of the 
RCRI (major surgery, coronary artery disease, renal insuf-
ﬁ  ciency, history of stroke, diabetes mellitus) (Fleisher et al 
2006). To complement clinical and functional assessment, 
cardiac testing should be selectively ordered to evaluate the 
extent of ischemic/valvular disease and their consequences 
on cardiac performances.
Echocardiographic examination is mandated in most 
patients with a history of acute pulmonary oedema, abnor-
mal clinical signs (heart murmur, ﬁ  ne crackles in basal lung 
areas, distended neck veins, peripheral oedema) and/or poor 
exercise tolerance ( 4 MET) (Lee et al 1999; Rohde et al 
2001).
For respiratory risk stratiﬁ  cation, patients should be 
speciﬁ  cally asked about the frequency of dyspnea and cough 
attacks, the intensity of medical treatment, smoking habits, 
previous hospital admission and recent infection (Smetana 
et al 2006). Procedure-related factors such as the site of 
incision, the duration of intervention and transfusion needs 
should be discussed with the surgeon, taking into account 
the presenting pathology and lesser invasive therapeutic 
approaches. Routine chest-X rays and functional labora-
tory testing are not helpful to further reﬁ  ne pulmonary 
risk assessment, except when the diagnosis of lung disease 
is unclear, in the case of clinical deterioration (ie, poorly 
controlled asthma, recent onset of fever or “greenish-yellow” 
sputum) and in patients scheduled to undergo lung resection. 
A large survey conducted in the United States revealed that 
anesthesiologists ordered preoperative lung function tests in 
approximately 60% of surgical candidates presenting with 
chronic lung diseases: 68% of patients with asthma, 80% of 
patients COPD and 53% of patients with severe scoliosis 
(Anon 2002).
Patient preparation
The preoperative setting provides a “teaching window” for 
effective encouragement of exercise training, smoking and 
alcohol cessation and instructions regarding chest physio-
therapy. For instance, education in lung expansion maneuvers 
reduces pulmonary complications to a greater degree when 
educative information is provided before, rather than after 
surgery (Castillo and Haas 1985). Muscular endurance train-
ing and re-nutrition may enhance respiratory muscle strength 
and facilitate weaning from the ventilator after major or 
prolonged operations. Interestingly, multidisciplinary reha-
bilitation programs have been shown to be cost-effective in 
severe COPD patients, compared with lung volume reduction 
surgery (Nici et al 2006).
Preoperative inhaled beta-2 adrenergic agonists (ie, 
salbutamol) and anticholinergic agents (ie, ipratropium) 
should be continued up to the day of surgery in all symptom-
atic asthmatics and in COPD patients with bronchial hyper-
reactivity. Short-term treatment with systemic or inhaled 
corticosteroids has been shown to “tune up” the lung function 
and to decrease the incidence of wheezing following endo-
tracheal intubation without increasing the risk of infection or 
wound dehiscence (Silvanus et al 2004). Antibiotics should 
be prescribed only when the character of sputum or bron-
choalveolar lavage ﬂ  uid suggests an infection and, whenever 
possible, the surgical procedure should be postponed for at 
least 10 days. Although theophylline is effective to attenuate 
bronchospasm and to strengthen diaphragmatic contractility, 
it is no longer a front-line drug to manage acute respiratory 
failure and it has the potential to produce fatal arrhythmias 
and convulsive episodes.
To prevent myocardial infarct, implementation of phar-
macological cardioprotective regimen is recommended in 
patients with known coronary artery disease or clinical risk 
factors (Fleisher et al 2006). Anti-adrenergic agents, platelet 
anti-aggregants and/or statins should be continued or started 
preoperatively (Karthikeyan and Bhargava 2006). Although 
beta-adrenergic blockers are contra-indicated in case of International Journal of COPD 2007:2(4) 506
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Table 5 Strategies to reduce the risk of major postoperative complications
Risk reduction strategy for postoperative  Strength of  Type of complications studied 
cardiac complications  evidence* 
Clinical risk stratiﬁ  cation  B  MI, CHF, arhythmia, operative mortality 
Smoking cessation  ?  MIsch 
Drugs  
 – Beta-adrenergic antagonists  A and B  MIsch, MI, CHF, arhythmia, short-long-term mortality
 – Alpha2-adrenergic agonists  B  Misch, MI, short-term mortality
 – Calcium-channel blockers  C  MI, CHF, arhythmia, short-term mortality
 – Statines  C  MI, short-long-term mortality
 – Aspirine  C  MI, short-long-term mortality 
Regional analgesia   
 – Thoracic epidural analgesia (intra-postoperative)  B  MI (mortality)
 – Spinal/Epidural analgesia  C  Mortality, deep venous thrombosis, PTE, (MI, stroke) 
Rewarming, normothermia  B  Misch 
Hematocrit   28%  C  Misch, serious cardiac adverse events 
Right heart catheterization  D  Mortality, arhythmia, thromboembolism 
Risk reduction strategy for postoperative   
pulmonary complications   
Clinical risk stratiﬁ  cation  C  Atelectasis, BPN, respiratory failure 
Smoking cessation preoperatively  I  postoperative ventilator support 
Monitoring of neuromuscular blockade and/or short-  B  Atelectasis, BPN 
acting myorelaxants   
Intraoperative neuraxial blockade vs general  C  Mortality, BPN, respiratory failure 
anesthesia 
Patient-controlled vs on-demand analgesia  C  pain score, overall complication, hospital length of stay
Neuraxial blockade post(-intra-) operative  C  miscellaneous PPCs 
Laparoscopic vs open procedures  C  Spirometry, atelectasis, BPN, overall PPC 
Selective nasogastric drainage  B  Atelectasis, BPN, bronchoaspiration 
Postoperative lung expansion modalities  B  Atelectasis, BPN, bronchitis, severe hypoxemia 
Nutrition  
 – routine parenteral or enteral nutrition  D 
 – immunonutrition  I 
Right heart catheterization  D  Pneumonia 
Risk reduction strategy for postoperative   
nonpulmonary INFECTIONS   
Hand washing (medical and nursing team)  A  Wound infection 
Antibiotic prophylaxis  A  Wound infection 
Blood glucose control  B  Wound infection 
Supplemental oxygen (intra-postop)  B  Wound infection 
Rewarming, normothermia  C  Wound infection 
Avoidance of indwelling catheters (central venous line,  C  Bacteriema, catheter-related sepsis, urinary infection 
bladder)  
Smoking cessation preop  C  Wound infection 
Abbreviations: MI, myocardial infarct; Misch, myocardial ischemia; CHF, congestive heart failure; PTE, pulmonary thromboembolism; BPN, bronchopneumonia.
A = good evidence that the strategy reduces complications and that beneﬁ  ts outweighs harms;
B = at least fair evidence that the strategy reduces complications;
C = at least fair evidence of positive impact although the harm and beneﬁ  t balance is too close to justify a general recommendation;
D = at least fair evidence that the strategy does not reduce complications or harmd outweigh beneﬁ  t;
I = insufﬁ  cient data.
moderate-to-severe bronchospastic disorders, a meta-analysis 
supports the safety of selective beta1-blockers in the majority 
of COPD patients in whom FEV1 remains stable. In these cir-
cumstances, inhaled beta-2 adrenergic agonists are still effective 
in alleviating acute bronchoconstrictive exacerbations, despite 
chronic beta-blockade (McGory et al 2005). Patients with com-
bined bronchospastic and coronary artery diseases might beneﬁ  t 
from the administration of alpha-2 adrenergic agonists (ie, 
clonidine, dexmedetomidine). Indeed, these agents are devoid 
of any bronchospastic effect and have been shown to prevent International Journal of COPD 2007:2(4) 507
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myocardial ischemia while reducing anesthetic/analgesic 
requirements and blunting thermoregulatory shivering during 
the perioperative period (Salpeter et al 2004).
Given the risk of sudden death and acute heart failure, 
postponing elective surgery is advisable in patients with 
recent cardiac symptoms (syncope, angina) and even in 
asymptomatic patients with high grade stenosis (mean trans-
valvular gradient  50 mm or valvular area  0.5cm2/m2) 
(Zahid et al 2005). For those with heart failure (NYHA class 
3 and 4), lesser invasive procedures should be considered 
and medical treatment should be carefully optimized by 
combining several drugs such as angiotensin converting 
enzyme inhibitors, angiotensin II antagonists, beta-adrenergic 
blockers and diuretics. In selected cases of heart failure (eg, 
bundle branch blockade), cardiac re-synchronization with 
multi-lead electrical stimulation might enhance ventricular 
performances and improve the short-term perioperative 
outcome.
Cessation of smoking shortly before cardiothoracic 
surgery (less than 2 months) has not been associated with 
signiﬁ  cant reduction in PPCs (Warner et al 1989; Barrera 
et al 2005). A “hang-over” effect comparable to delirium 
and increased sputum production may actually increase the 
risk of PPCs, particularly atelectasis and silent bronchoaspi-
ration. Smoking cessation is successful in less than 30% of 
cases. Fewer tissue-healing problems and PPCs have been 
observed only after more than 8 weeks of smoking cessa-
tion, compared with non-smoking patients (Moller et al 
2002; Barrera et al 2005). Overwhelming health beneﬁ  ts in 
smoking cessation accrue with increasing duration of absti-
nence. Firstly, carboxyhemoglobin levels decrease and the 
excitatory effects of nicotine are abolished within 48 hours. 
Respiratory symptoms improve after 4 to 6 weeks, with 
FEV1 increasing within the ﬁ  rst year. The risks for ischemic 
myocardial and cerebrovascular events are reduced after 2–5 
years and lower risk for cancer are observed after 5–9 years 
(Warner 2006).
Hospital structures and health care 
processes
Volume of procedures and structural aspects
Besides specialized health care training, professional 
expertise and technical skills, the operative outcome is largely 
inﬂ  uenced by the number of major procedures performed at a 
single institution, emphasizing the critical importance of the 
organizational processes and a multidisciplinary coordinated 
team approach (Licker et al 2001; Birkmeyer and Birkmeyer 
2006). In these large-volume hospitals and health networks, 
better results in terms of patient mortality/morbidity data and 
cost containment can be achieved by adopting stringent safety 
practices, implementing organ protective strategies, standard-
izing the processes of care and deﬁ  ning clinical pathways for 
homogeneous groups of patients. In several leading American 
hospitals, health care quality-improvement projects are 
focused on speciﬁ  c targets such as the perioperative use of 
beta-blockers, computerization of the medical and nursing 
ﬁ  les as well as the 24h availability of high-dependency units. 
Hence, some health authorities and insurance companies 
recommend the referral of higher-risk patients and complex 
operations to high-volume hospitals where all necessary 
supporting facilities are available and where evidence-based 
and cost-efﬁ  cient medical interventions and nursing care are 
more likely to be applied.
Minimally-invasive procedures
Compared with the “open” standard operations, minimally-
invasive procedures (eg, endovascular aortic prothesis, 
laparoscopy) produce lesser tissue damage and in turn, an 
attenuated neurohumoral and inﬂ  ammatory response (Ciofolo 
et al 1990; Hasukic et al 2002). Consequently, the minimally-
invasive approach confers major advantages in terms of 
shorter hospital stay, earlier ambulation and feeding, with 
lesser need for analgesic medications and better preservation 
of lung functional volume (Johnson et al 2005; Aziz et al 
2006). For COPD patients who require an “open” aortic ab-
dominal reconstruction, the retro-peritoneal approach should 
be preferred as it produces lesser impairment in respiratory 
function and fewer PPCs than the classical median lapa-
rotomy (Compton et al 2005).
Nasogastric drainage
Routine nasogastric drainage fails to accelerate bowel recov-
ery and may even increase the risk of silent bronchoaspira-
tion. Randomized controlled trials have shown that selective 
nasogastric drainage resulted in earlier bowel functioning 
and fewer PPCs compared with routine gastric drainage 
(Nelson et al 2005). Hence, the indications for nasogastric 
decompression should be limited to emergency situations 
(acute abdomen, head trauma, drug overdose), symptomatic 
abdominal distension and recurrent nausea or vomiting.
Anesthetic agents and techniques
General anesthesia
Whenever possible, central neuraxial blockade, peripheral 
nerve blockade or general anesthesia without tracheal intu-
bation are preferentially considered in COPD patients. The 
new laryngeal masks offer the advantage of lesser upper International Journal of COPD 2007:2(4) 508
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airways irritation compared with endotracheal tubes; various 
modes of spontaneous assisted ventlation, pressure support 
ventilation or volume-controlled ventilation can be applied 
depending on the patient’s respiratory status and the planned 
intervention (Berry et al 1999).
Following endotracheal intubation, wheezing is more 
likely to occur when barbiturates are used as anesthetic 
induction agents, compared with propofol, ketamine or vola-
tile anesthetics (Brown and Wagner 1999; Goff et al 2000). 
To attenuate the bronchoconstrictive reﬂ  ex due to endotra-
cheal intubation or suctioning, prophylactic treatments with 
lidocaine (intravenous or inhaled) and/or a beta2-adrenergic 
agonist are recommended in asthmatic and COPD patients 
with bronchospastic response (Groeben, Schlicht et al 2002). 
Intravenous lidocaine doses of 1–2 mg/kg of body weight 
have been shown to attenuate histamine-induced bronchocon-
striction in asthmatic volunteers whereas nebulized lidocaine 
produces transient airway irritation followed by blunted 
bronchial reactivity that occurs at lower plasma concentra-
tions than following systemic administration.
As pointed out previously, volatile anesthetics are 
effective bronchodilating agents and are currently recom-
mended for anesthesia maintenance in COPD patients with 
hyperreactive airways (Rooke et al 1997; Volta et al 2005). 
With respect to their efﬁ  cacy in treating intraoperative bron-
chospasm, volatile anesthetics are equipotent (isoﬂ  urane, 
desﬂ  urane, sevoﬂ  urane), except desﬂ  urane which may even 
provoke coughing, bronchospasm, laryngospasm and bron-
chial hypersecretion (Dikmen et al 2003). In rare cases where 
hypoxemia is attributed to the inhibition of HPV response, 
administration of volatile anesthetics should be interrupted 
and replaced by a continuous infusion of intravenous propofol 
or ketamine.
When muscle relaxants are needed, short-acting agents 
are titrated to maintain an adequate depth of muscular 
blockade as assessed by neuromuscular testing. Residual 
neuromuscular blockade should be reversed before tracheal 
extubation with the administration of cholinesterase inhibi-
tors (prostigmine).
Controlled mechanical ventilation and inspiratory 
oxygen fraction
In patients with healthy lungs, lung recruitment maneuvers 
are more effective than application of continuous PEEP to 
prevent or reverse intra-operative atelectasis (Rothen et al 
1999; Oczenski et al 2004). Re-opening 50%–100% of atel-
ectatic areas requires that a plateau airway pressure of 30 to 
40 cm H2O should be maintained for 7 seconds in patients 
with healthy lungs. Such a large inﬂ  ation corresponds to the 
maximal inspiratory volume (vital capacity) which may tran-
siently compromise hemodynamics by inﬂ  uencing preload, 
afterload and contractility of the ventricules. In morbidly 
obese patients, Wahlen et al demonstrated the efﬁ  cacy of 
alveolar recruitment to improve oxygenation. However, the 
positive ventilatory effects were short lived and associated 
with greater requirements for vasopressors (Whalen FX 
et al 2006).
In COPD patients, intermittent positive pressure ventila-
tion (IPPV) may aggravate dynamic hyperinﬂ  ation and cause 
premature closure of small airways leading to further venti-
lation/perfusion mismatch (Alvisi et al 2003). Accordingly, 
ventilatory settings should be precisely adjusted to maximize 
alveolar gas emptying and to avoid dynamic hyperinﬂ  ation 
(low frequency rate, inspiratory/expiratory ratio; intrinsic 
PEEP) (Figure 2).
The pressure ventilatory mode (PV) with a decelerating 
ﬂ  ow has the potential advantage of decreasing the peak air-
way pressure and providing more homogenous distribution 
of inspiratory air ﬂ  ow at a lower or similar mean distend-
ing pressure (Yu et al 2006). The continuous airﬂ  ow from 
a bi-level positive airway pressure ventilator (BiPAP: two 
different levels of inspiratory and expiratory airway pres-
sure) may deliver adaptive pressures to prevent the dynamic 
airway collapse which tend to occur with standard ventilation 
in COPD patients (Ferrer et al 2002). The ﬂ  ow triggering 
during BiPAP allows spontaneous breathing throughout the 
mechanical ventilatory cycle, enabling unrestricted move-
ment of the diaphragm. In postoperative patients and in 
animal experiments with bronchoconstriction, BiPAP has 
been shown to improve ventilation-perfusion mismatch and 
blood gas exchange when compared with conventional IPPV 
(with or without PEEP).
In patients with ALI, setting PEEP slightly higher than the 
lower inﬂ  ection point on the pressure-volume curve and limit-
ing the tidal ventilation volume (5–7 ml/kg) have been shown 
to prevent cyclic atelectasis, to attenuate the mechanical and 
biological stress acting at the alveolar-capillary level and to 
improve postoperative outcome (Moran et al 2005). Similar 
protective ventilatory settings have been demonstrated to 
blunt the pulmonary inﬂ  ammatory responses; accordingly, 
BiPAP or PV with low tidal volume and lung recruitment 
maneuvers are currently advocated during major operations, 
particularly lung resection in COPD patients (Licker, de 
Perrot et al 2003; Fernandez-Perez et al 2006).
Besides i.v. antibiotic prophylaxis and maintenance 
of normothermia and normoglycemia, the delivery of a International Journal of COPD 2007:2(4) 509
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high-percentage of inhaled oxygen (80% intraoperatively and 
supplemental oxygen up to 2 hours after surgery) has been 
shown to lower the risk of wound infections while it may 
potentially increase the production of oxygen-derived free 
radicals (Belda et al 2005). Although formation of resorption 
atelectasis occurs in all patients breathing pure O2 within 
7 min after anesthesia induction, the amount of atelectatic 
areas is much less in patients ventilated with 80% O2 inspi-
ratory concentration and almost absent in those ventilated 
with 60%.129 Accordingly, prevention of complete alveolar 
gas resorption and preservation of bactericidal activity of 
inﬂ  ammatory cells can be achieved by setting the inspiratory 
O2 fraction between 50%–80% and by performing periodic 
“vital capacity manoeuvers”. These new proposals contrast 
with the current practice of setting the lowest inspiratory O2 
fraction, usually around 30% that theoretically minimizes 
the risk of oxidative damage.
Regional anesthesia and analgesia
Provision of effective static and dynamic pain relief is a pre-
requisite for an accelerated postoperative recovery. Regional 
anesthetic techniques and patient-controlled rather than 
“on demand” drug regimen are the cornerstone of modern 
analgesic strategies. By combining different analgesic agents 
(opioids, paracetamol, non-steroidal anti-inflammatory 
drugs), the effectiveness of pain control may be further 
increased while drug-related side-effects are minimized 
(sedation, respiratory depression, nausea and vomiting) (Elia 
et al 2005; Marret et al 2005).
Several meta-analysis support the concept that regional 
anesthetic techniques improve surgical outcome not only 
through better pain control but also through attenuation of 
the neuroendocrine response to surgery, maintenance of the 
immune function, improvement of tissue oxygenation and 
modulation of the catabolic phase. The use of intraopera-
tive central neuraxial techniques (spinal/epidural) has been 
associated with reduced operative mortality rates and fewer 
episodes of deep vein thrombosis, pulmonary embolism and 
stroke as well as a lower need for blood transfusion. Like-
wise, maintenance of thoracic epidural analgesia (TEA) for 
several days after major abdominal and thoracic surgery has 
been shown to reduce the operative mortality rate as well as 
the incidence of myocardial infarct, arrhythmia, atelectasis, 
bronchopneumonia and respiratory failure (Beattie et al 
2001; Rigg et al 2002; Lawrence et al 2006; Licker et al 
2006). By blocking the afferent nociceptive stimuli and 
inhibiting the efferent sympathetic outﬂ  ow, TEA affords 
cardiac and pulmonary protection as demonstrated by 
improvement of myocardial oxygen balance, inhibition of 
platelet hyperaggregability, limitation of myocardial infarct 
size and preservation of diaphragmatic function (Pansard 
et al 1993; Polaner et al 1993; Groban et al 1999; Liu et al 
2004). In addition, the time to extubation is shortened in 
patients with TEA as lower doses of opiates and anesthetic 
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drugs are administered intraoperatively. Faster recovery of 
bowel motility allows early resumption of oral intake and 
blunting of protein catabolism facilitates rapid mobilization, 
avoiding the consequences of bed rest with muscle wasting, 
fatigue and venous thrombosis (Carli et al 2002).
Compared with epidural analgesic techniques, a single 
shot of intra-thecal morphine (0.2–1 mg) at the lumbar site is 
simpler, faster and more easily performed by non-experienced 
hands. A recent meta-analysis including 668 surgical patients 
failed to document any beneﬁ  t in terms of mortality and major 
cardiopulmonary complications following cardiac surgery 
(Liu et al 2004). Nevertheless, much lower doses of opiates 
are required to provide analgesia through the epidural/spinal 
route. For instance, intra-thecal morphine is 100 times more 
potent than after systemic injection, due to the presence of 
opioid receptors in the substantia gelatinosa of the spinal 
cord. Clinical studies have demonstrated the beneﬁ  cial 
effects of intra-thecal opiates on several surrogate endpoints: 
modulating the perioperative stress response, alleviating pain 
for the ﬁ  rst 24 hours after surgery, shortening the extubation 
time and improvement of the early postoperative respiratory 
function (Liu et al 2004). Importantly, the dose-related respi-
ratory depressive effect of intra-thecal morphine mandates 
close monitoring within the ﬁ  rst 24 hours after the injection 
of doses exceeding 0.5 mg (Bailey et al 1993).
Despite the undisputable advantages of central neuraxial 
techniques, concerns have been raised regarding two types of 
catastrophic complications: cardiac arrests due to anesthetic 
overdose or concurrent sedation (2.5–6.4 per 10,000 spinal 
anesthesia; 0–2.5 per 10,000 epidural anesthesia) and spinal 
hematoma with paraplegic syndrome (1/1,150,000 with 
epidural anesthesia and 1/220,000 with spinal anesthesia) 
(Horlocker et al 2003). For understandable reasons, fear of 
spinal hematoma and nerve injuries will continue to discour-
age some anesthesiologists to perform regional anesthetic 
techniques in low risk patients in whom various combinations 
of parenteral opiates, non-steroidal anti-inﬂ  ammatory drugs 
and paracetamol might be preferred. In contrast, in patients 
at higher risk for cardiopulmonary complications, the risk-
beneﬁ  t analysis speaks in favor of central neuraxial blockade. 
These important issues should be discussed preoperatively 
with each patient. For instance, surgical candidates under-
going major aortic surgery have an average 3%–5% risk of 
myocardial infarct and 5%–10% risk of PPCs. Considering 
the fact that central neuraxial blockade confers a median 
30% to 50% relative risk reduction for cardiac and pulmonary 
complications, then one myocardial infarct and one PPC can 
be avoided for every 30 to 60 treated patients. Furthermore, 
for each person suffering a spinal hematoma (1 in 150,000), 
it may be estimated that TEA may prevent at least 40 to 100 
deaths in the high-risk group of COPD patients undergoing 
major surgery.
Monitoring
Although no single monitoring device has been shown to 
improve outcome in the operating room and ICU, the com-
bination of ECG, pulse oxymetry, blood pressure monitoring 
and capnography may identify critical cardio-pulmonary 
events and trigger corrective measures. Given the lack of 
beneﬁ  ts and the added risk related to right heart catheteriza-
tion, there is a trend towards using lesser invasive monitor-
ing tools such as Doppler ultrasound, arterial pulse contour 
analysis and the simple thermodilution technique, to assess 
the blood circulating volume, the extravascular lung water 
content and ventricular contractility indices (Rocco et al 
2004; Cholley and Payen 2005). Future clinical studies are 
still warranted to demonstrate the outcome beneﬁ  ts of goal-
oriented hemodynamic treatments.
As moderate levels of hypothermia (34 °C–35 °C) have 
been associated with higher incidences of myocardial 
ischemia and wound infection, body temperature should be 
measured and kept above 36 °C by preventing heat losses 
and using warming devices (pulsed air blanket, ﬂ  uid infusion 
warmers, warm mattress devices).
Monitoring the neuromuscular function is mandatory 
to ascertain both the depth of muscular relaxation and the 
functional recovery before tracheal extubation. The ability 
to raise the head for 5 seconds, to open the eyes on demand 
or to take a deep inspiratory breath are unreliable signs of 
neuromuscular recovery and should be routinely comple-
mented by neuromuscular testing (Pino 2006). Different 
modes of electrical stimulation have been proposed, of which 
the train-of-four and double-burst methods are widely used. 
Squeletal muscles vary greatly in their sensitivity to muscle 
relaxants: the diaphragm being the most resistant whereas 
the peripheral small muscles of the hands and feet, the 
upper airway and the pharyngeal muscles are more sensitive 
(Eriksson 1994).
Improved processing of electroencephalographic signals 
and evoked potentials may be helpful to target an adequate 
depth of anesthesia. Preliminary evidence indicates that the 
administration of general anesthetics guided by the bispec-
tral index of the electroencephalogram lowers the risk for 
intraoperative awareness and might even improve the overall 
postoperative outcome (Anon 2006). Indeed, two prospec-
tive studies including more than 6,000 patients demonstrated International Journal of COPD 2007:2(4) 511
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that deeper maintenance of anesthetic levels was associated 
with higher 1-year postoperative death rates in patients aged 
40 years or more undergoing major noncardiac surgery 
(Ekman et al 2004; Monk et al 2005). The risk of death within 
1-year after surgery increased nearly 20% for every hour that 
a patient had a bispectral index monitor score of less than 45 
(indicating excessive deep hypnotic levels).
Lung expansion maneuvers
To complement the intraoperative vital capacity maneuvers, 
various techniques of respiratory physiotherapy such as 
incentive spirometry, deep breathing exercises, diaphrag-
matic breathing, intermittent positive-pressure breathing, 
continuous positive airway pressure (CPAP) or non-invasive 
positive pressure ventilation (NIPPV) are currently applied 
to prevent the postoperative fall in functional lung volume 
and/or to re-open atelectatic areas. Although several bias 
limit the interpretation of most clinical studies (inclusion 
of low risk groups, poorly deﬁ  ned clinical endpoints, non-
standardized respiratory interventions), a meta-analysis 
of 14 randomized controlled trials suggests that incentive 
spirometry and deep breathing exercises each reduces by 
about 50% the risk of postoperative complications. The 
combination of these techniques fails to confer additional 
beneﬁ  t (Thomas and McIntosh 1994).
Patient’s empowerment can be reinforced by an informa-
tive preoperative consultation including practical demonstra-
tion of prophylactic respiratory maneuvers which are aimed 
to reverse the diaphragmatic dysfunction consequent to upper 
abdominal and thoracic surgery (Mackay et al 2005). The 
positive impact of optimal analgesia without undue sedation 
and early mobilization should also be emphasized.
Prophylactic application of CPAP or NIPPV is equally 
effective but less cost-efficient, as it requires more 
sophisticated devices and the availability of trained hospital 
personnel. The use of CPAP should be restricted for patients 
unable to perform deep breathing exercises (or incentive 
spirometry). NIPPV which delivers positive pressure support 
ventilation plus PEEP via a face-mask, has emerged as a 
signiﬁ  cant advance in the management of OAS, cardiogenic 
pulmonary edema and respiratory failure, particularly in 
postoperative patients and those with an acute exacerba-
tion of COPD (Joris et al 1997, 2005; Ram et al 2005; 
Squadrone et al 2005; Fernandez-Perez et al 2006; Yu et al 
2006). In obese patient following gastroplasty, application of 
prophylactic NIPPV has been shown to reduce the magnitude 
of the restrictive lung syndrome (Joris et al 1997). By unload-
ing the inspiratory muscles and improving gas exchanges, 
NIPPV avoids the need to re-intubate the patients and thereby 
lowers the risks of nosocomial infections.
Fluid infusion
To date, algorithms guiding perioperative ﬂ  uid administra-
tion are based on the empiric assumptions that preoperative 
deﬁ  cits, maintenance ﬂ  uids, third space losses and blood 
loss should be replaced by crystalloids or a combination of 
colloids and crystalloids. For major abdominal surgery, the 
proposed rule to infuse large quantities of salts and ﬂ  uids 
(crystalloids 10–15 ml/kg/h intraoperatively followed by 
1.5–2 L per day postoperatively), results in a positive ﬂ  uid 
balance of 1–3 L and a body weight gain often exceeding 
10% over the ﬁ  rst 3 postoperative days (Grocott et al 2005). 
Excessive intravascular plasma volume leads to extravascular 
water accumulation and tissue edema that will predispose 
these patients to respiratory/heart failure, wound infection, 
anastomotic dehiscence and prolong ileus prohibiting oral 
feeding. In a large retrospective study, Arieff (1999) found 
that acute pulmonary edema occurred in 7.6% of patients 
undergoing various surgical procedures (n = 612/8052). 
Interestingly, overzealous hydration leading to a net ﬂ  uid 
retention exceeding 90 ml/kg/day was the sole contributory 
factor in 2.6% of patients, being free from any cardiopul-
monary disease.
Based on prospective controlled studies, two strategies 
of ﬂ  uid infusion have been proposed: (1) hemodynamic-
goal directed ﬂ  uid loading aimed at increasing cardiac out-
put and correcting “silent” hypovolemia, and (2) restrictive 
ﬂ  uid administration (no compensation for third space 
losses and combined epidural blockade) continued over 
2–3 days and targeting a maximal weight gain of 10% 
(Grocott et al 2005).
A “dry” fluid regimen has been widely adopted in 
pulmonary surgery resulting in a decreased risk of ALI. In 
major abdominal surgery, three randomized controlled trials 
support the safety and beneﬁ  cial effects of the restrictive 
approach: hemodynamics remained stable, renal function 
was not impaired, fewer patients experience complications, 
gastrointestinal function recovered earlier and time to hos-
pital discharge was shorter (Grocott et al 2005).
Conclusion
To date, perioperative physicians are confronted with 
increasing numbers of patients with COPD and cardiovascular 
diseases who should not be denied appropriate surgical treat-
ments. Besides patient’s comorbidities, procedure-related fac-
tors (thoracic and upper abdominal interventions, prolonged International Journal of COPD 2007:2(4) 512
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surgery) are the main risk factors for PPCs and cardiac adverse 
events that will markedly impact on long-term patient sur-
vival, hospital resource and health care costs.
Strong scientiﬁ  c evidence supports the concept that 
patient safety and surgical outcome may be improved by 
preoperative screening of these high risk patients, optimisa-
tion of organ function, control of the neuroendocrine and 
inﬂ  ammatory response as well as standardization of health 
care processes.
Several advances in surgery and anesthesia care 
have been shown to be particularly beneﬁ  cial in COPD 
patients:
•  Minimally-invasive procedures and selective nasogastric 
drainage
•  Implementation of cardioprotective strategies (eg, 
beta-blockers, platelet anti-aggregants, alpha2-agonists, 
statines, thoracic epidural analgesia)
•  Regional anesthetic blockade and laryngeal masks to 
minimize airway instrumentation
•  Volatile anesthetic agents with bronchodilating properties 
(eg, sevoﬂ  urane)
•  Physiological monitoring in order to target the adequate 
circulatory volume, blood gas exchanges, depth of anes-
thesia and neuromuscular activity
•  Prevention and treatment of atelectasis by lung recruit-
ment maneuvers while avoiding stress-induced lung 
injuries (low tidal volume ventilation)
•  Multimodal analgesic regimen for blocking nociceptive 
inputs
•  Fast-track anesthesia and NIPPV to avoid the deleterious 
effects of tracheal intubation and prolonged mechanical 
ventilation.
•  Maintenance of normothermia, tight control of blood 
glucose and provision of supplemental oxygen to reduce 
wound infection
•  Adjustment of ﬂ  uid infusion (colloids, cristalloids, blood 
products) to maintain an adequate circulatory volume, 
blood coagulation and oxygen delivery to all tissues
References
Alvisi V, Romanello A, Badet M, et al. 2003. Time course of expiratory ﬂ  ow 
limitation in COPD patients during acute respiratory failure requiring 
mechanical ventilation. Chest, 123:1625–32.
[Anon]. 2002. Practice advisory for preanesthesia evaluation: a report by 
the American Society of Anesthesiologists Task Force on Preanesthesia 
Evaluation. Anesthesiology, 96:485–96.
[Anon]. 2006. Practice advisory for intraoperative awareness and brain func-
tion monitoring: a report by the american society of anesthesiologists 
task force on intraoperative awareness. Anesthesiology, 104:847–64.
Arieff AI. 1999. Fatal postoperative pulmonary edema: pathogenesis and 
literature review. Chest, 115:1371–7.
Arozullah AM, Daley J, Henderson WG, et al. 2000. Multifactorial risk 
index for predicting postoperative respiratory failure in men after major 
noncardiac surgery The National Veterans Administration Surgical 
Quality Improvement Program. Ann Surg, 232:242–53.
Arozullah AM, Khuri SF, Henderson WG, et al. 2001. Development 
and validation of a multifactorial risk index for predicting postop-
erative pneumonia after major noncardiac surgery. Ann Intern Med, 
135:847–57.
Aschkenasy SV, Hofer CK, Zalunardo MP, et al. 2005. Patterns of changes in 
arterial PO2 during one-lung ventilation: a comparison between patients 
with severe pulmonary emphysema and patients with preserved lung 
function. J Cardiothorac Vasc Anesth, 19:479–84.
Aziz O, Constantinides V, Tekkis PP, et al. 2006. Laparoscopic versus 
open surgery for rectal cancer: a meta-analysis. Ann Surg Oncol, 
13:413–24.
Babenco HD, Blouin RT, Conard PF, et al. 1998. Diphenylhydramine 
increases ventilatory drive during alfentanil infusion. Anesthesiology, 
89:642–7.
Bailey PL, Rhondeau S, Schafer PG, et al. 1993. Dose-response pharma-
cology of intrathecal morphine in human volunteers. Anesthesiology, 
79:49–59.
Bardoczky GI, Szegedi LL, d’Hollander AA, et al. 2000. Two-lung and one-
lung ventilation in patients with chronic obstructive pulmonary disease: 
the effects of position and F(IO)2. Anesth Analg, 90:35–41.
Barrera R, Shi W, Amar D, et al. 2005. Smoking and timing of cessa-
tion: impact on pulmonary complications after thoracotomy. Chest, 
127:1977–83.
Beattie WS, Badner NH, Choi P. 2001. Epidural analgesia reduces 
postoperative myocardial infarction: a meta-analysis. Anesth Analg, 
93:853–8.
Belda FJ, Aguilera L, Garcia de la Asuncion J, et al. 2005. Supplemental 
perioperative oxygen and the risk of surgical wound infection: a ran-
domized controlled trial. Jama, 294:2035–42.
Berg H, Roed J, Viby-Mogensen J, et al. 1997. Residual neuromuscular 
block is a risk factor for postoperative pulmonary complications. 
A prospective, randomised, and blinded study of postoperative pul-
monary complications after atracurium, vecuronium and pancuronium. 
Acta Anaesthesiol Scand, 41:1095–103.
Berry A, Brimacombe J, Keller C, et al. 1999. Pulmonary airway resistance 
with the endotracheal tube versus laryngeal mask airway in paralyzed 
anesthetized adult patients. Anesthesiology, 90:395–7.
Birkmeyer NJ, Birkmeyer JD. 2006. Strategies for improving surgical 
quality – should payers reward excellence or effort? N Engl J Med, 
354:864–70.
Boersma E, Kertai MD, Schouten O, et al. 2005. Perioperative cardiovascular 
mortality in noncardiac surgery: validation of the Lee cardiac risk index. 
Am J Med, 118:1134–41.
Bonnet F, Marret E. 2005. Inﬂ  uence of anaesthetic and analgesic techniques 
on outcome after surgery. Br J Anaesth, 95:52–8.
Brown RH, Wagner EM. 1999. Mechanisms of bronchoprotection by 
anesthetic induction agents: propofol versus ketamine. Anesthesiol-
ogy, 90:822–8.
Bruce J, Russell EM, Mollison J, et al. 2001. The measurement and monitor-
ing of surgical adverse events. Health Technol Assess, 5:1–194.
Buhre W, Rossaint R. 2003. Perioperative management and monitoring in 
anaesthesia. Lancet, 362:1839–46.
Burnham EL, Moss M, Harris F, et al. 2004. Elevated plasma and lung endo-
thelial selectin levels in patients with acute respiratory distress syndrome 
and a history of chronic alcohol abuse. Crit Care Med, 32:675–9.
Carli F, Mayo N, Klubien K, et al. 2002. Epidural analgesia enhances func-
tional exercise capacity and health-related quality of life after colonic 
surgery: results of a randomized trial. Anesthesiology, 97:540–9.
Castillo R, Haas A. 1985. Chest physical therapy: comparative efﬁ  cacy of 
preoperative and postoperative in the elderly. Arch Phys Med Rehabil, 
66:376–9.
Cholley BP, Payen D. 2005. Noninvasive techniques for measurements of 
cardiac output. Curr Opin Crit Care, 11:424–9.International Journal of COPD 2007:2(4) 513
COPD and surgery
Christ M, Sharkova Y, Geldner G, et al. 2005. Preoperative and perioperative 
care for patients with suspected or established aortic stenosis facing 
noncardiac surgery. Chest, 128:2944–53.
Ciofolo MJ, Clergue F, Seebacher J, et al. 1990. Ventilatory effects of 
laparoscopy under epidural anesthesia. Anesth Analg, 70:357–61.
Compton CN, Dillavou ED, Sheehan MK, et al. 2005. Is abdominal aortic 
aneurysm repair appropriate in oxygen-dependent chronic obstructive 
pulmonary disease patients? J Vasc Surg, 42:650–3.
Creekmore FM, Lugo RA, Weiland KJ. Postoperative opiate analgesia 
requirements of smokers and nonsmokers. Ann Pharmacother, 
38:949–53.
Dahan A, Romberg R, Teppema L, et al. 2004. Simultaneous measurement 
and integrated analysis of analgesia and respiration after an intravenous 
morphine infusion. Anesthesiology, 101:1201–9.
den Herder C, Schmeck J, Appelboom DJ, et al. 2004. Risks of general 
anaesthesia in people with obstructive sleep apnea. Bmj, 329:955–9.
Dikmen Y, Eminoglu E, Salihoglu Z, et al. 2003. Pulmonary mechanics 
during isoﬂ  urane, sevoﬂ  urane and desﬂ  urane anaesthesia. Anaesthesia, 
58:745–8.
Dindo D, Demartines N, Clavien PA. 2004. Classiﬁ  cation of surgical com-
plications: a new proposal with evaluation in a cohort of 6336 patients 
and results of a survey. Ann Surg, 240:205–13.
Drongowski RA, Lee D, Reynolds PI, et al. 2003. Increased respiratory 
symptoms following surgery in children exposed to environmental 
tobacco smoke. Paediatr Anaesth, 13:304–10.
Eikermann M, Blobner M, Groeben H, et al. 2006. Postoperative upper 
airway obstruction after recovery of the train of four ratio of the 
adductor pollicis muscle from neuromuscular blockade. Anesth Analg, 
102:937–42.
Ekman A, Lindholm ML, Lennmarken C, et al. 2004. Reduction in the 
incidence of awareness using BIS monitoring. Acta Anaesthesiol 
Scand, 48:20–6.
Elia N, Lysakowski C, Tramer MR. 2005. Does multimodal analgesia 
with acetaminophen, nonsteroidal antiinﬂ  ammatory drugs, or selective 
cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine 
offer advantages over morphine alone? Meta-analyses of randomized 
trials. Anesthesiology, 103:1296–304.
Ergin A, Muntner P, Sherwin R, et al. 2004. Secular trends in cardiovascu-
lar disease mortality, incidence, and case fatality rates in adults in the 
United States. Am J Med, 117:219–27.
Eriksson LI. 1994. Ventilation and neuromuscular blocking drugs. Acta 
Anaesthesiol Scand Suppl, 102:11–5.
Fernandez-Perez ER, Keegan MT, Brown DR, et al. 2006. Intraoperative 
tidal volume as a risk factor for respiratory failure after pneumonectomy. 
Anesthesiology, 105:14–8.
Ferrer M, Iglesia R, Roca J, et al. 2002. Pulmonary gas exchange 
response to weaning with pressure-support ventilation in exacerbated 
chronic obstructive pulmonary disease patients. Intensive Care Med, 
28:1595–9.
Fisher BW, Majumdar SR, McAlister FA. 2002. Predicting pulmonary 
complications after nonthoracic surgery: a systematic review of blinded 
studies. Am J Med, 112:219–25.
Fleischmann KE, Goldman L, Young B, et al. 2003. Association between 
cardiac and noncardiac complications in patients undergoing non-
cardiac surgery: outcomes and effects on length of stay. Am J Med, 
115:515–20.
Fleisher LA, Beckman JA, Brown KA, et al. 2006. ACC/AHA 2006 guide-
line update on perioperative cardiovascular evaluation for noncardiac 
surgery: focused update on perioperative beta-blocker therapy: a report 
of the American College of Cardiology/American Heart Association 
Task Force on Practice Guidelines. Circulation, 113:2662–74.
Goff MJ, Arain SR, Ficke DJ, et al. 2000. Absence of bronchodilation dur-
ing desﬂ  urane anesthesia: a comparison to sevoﬂ  urane and thiopental. 
Anesthesiology, 93:404–8.
Gorman RB, McKenzie DK, Pride NB, et al. 2002. Diaphragm length during 
tidal breathing in patients with chronic obstructive pulmonary disease. 
Am J Respir Crit Care Med, 166:1461–9.
Groban L, Zvara DA, Deal DD, et al. 1999. Thoracic epidural anesthesia 
reduces infarct size in a canine model of myocardial ischemia and 
reperfusion injury. J Cardiothorac Vasc Anesth, 13:579–85.
Grocott MP, Mythen MG, Gan TJ. 2005. Perioperative ﬂ  uid management 
and clinical outcomes in adults. Anesth Analg, 100:1093–106.
Groeben H, Schafer B, Pavlakovic G, et al. 2002. Lung function under high 
thoracic segmental epidural anesthesia with ropivacaine or bupivacaine 
in patients with severe obstructive pulmonary disease undergoing breast 
surgery. Anesthesiology, 96:536–41.
Groeben H, Schlicht M, Stieglitz S, et al. 2002. Both local anesthetics and 
salbutamol pretreatment affect reﬂ  ex bronchoconstriction in volunteers 
with asthma undergoing awake ﬁ  beroptic intubation. Anesthesiology, 
97:1445–50.
Groeben H, Schwalen A, Irsfeld S, et al. 1994. High thoracic epidural anes-
thesia does not alter airway resistance and attenuates the response to an 
inhalational provocation test in patients with bronchial hyperreactivity. 
Anesthesiology, 81:868–74.
Gunnarsson L, Tokics L, Gustavsson H, et al. 1991. Inﬂ  uence of age on 
atelectasis formation and gas exchange impairment during general 
anaesthesia. Br J Anaesth, 66:423–32.
Gunnarsson L, Tokics L, Lundquist H, et al. 1991. Chronic obstructive 
pulmonary disease and anaesthesia: formation of atelectasis and gas 
exchange impairment. Eur Respir J, 4:1106–16.
Halbert RJ, Natoli JL, Gano A, et al. 2006. Global burden of COPD: sys-
tematic review and meta-analysis. Eur Respir J, 28:523–32.
Hasukic S, Mesic D, Dizdarevic E, et al. 2002. Pulmonary function after 
laparoscopic and open cholecystectomy. Surg Endosc, 16:163–5.
Hedenstierna G, Edmark L. 2005. The effects of anesthesia and muscle 
paralysis on the respiratory system. Intensive Care Med, 31:1327–35.
Hedenstierna G, Rothen HU. 2000. Atelectasis formation during anesthesia: 
causes and measures to prevent it. J Clin Monit Comput, 16:329–35.
Hernandez AF, Whellan DJ, Stroud S, et al. 2004. Outcomes in heart 
failure patients after major noncardiac surgery. J Am Coll Cardiol, 
44:1446–53.
Hodgson PS, Liu SS. 2001. Epidural lidocaine decreases sevoﬂ  urane require-
ment for adequate depth of anesthesia as measured by the Bispectral 
Index monitor. Anesthesiology, 94:799–803.
Horlocker TT, Wedel DJ, Benzon H, et al. 2003. Regional anesthesia in the 
anticoagulated patient: deﬁ  ning the risks (the second ASRA Consensus 
Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth 
Pain Med, 28:172–97.
Jaber S, Delay JM, Chanques G, et al. 2005. Outcomes of patients with acute 
respiratory failure after abdominal surgery treated with noninvasive 
positive pressure ventilation. Chest, 128:2688–95.
Johnson N, Barlow D, Lethaby A, et al. 2005. Methods of hysterectomy: 
systematic review and meta-analysis of randomised controlled trials. 
Bmj, 330:1478.
Joris JL, Sottiaux TM, Chiche JD, et al. 1997. Effect of bi-level positive 
airway pressure (BiPAP) nasal ventilation on the postoperative pulmo-
nary restrictive syndrome in obese patients undergoing gastroplasty. 
Chest, 111:665–70.
Kaafarani HM, Itani KM, Thornby J, et al. 2004. Thirty-day and one-year 
predictors of death in noncardiac major surgical procedures. Am J 
Surg, 188:495–9.
Karthikeyan G, Bhargava B. 2006. Managing patients undergoing non-
cardiac surgery: need to shift emphasis from risk stratiﬁ  cation to risk 
modiﬁ  cation. Heart, 92:17–20
Kertai MD, Bountioukos M, Boersma E, et al. 2004. Aortic stenosis: an 
underestimated risk factor for perioperative complications in patients 
undergoing noncardiac surgery. Am J Med, 116:8–13.
Kleinman BS, Frey K, VanDrunen M, et al. 2002. Motion of the diaphragm 
in patients with chronic obstructive pulmonary disease while spontane-
ously breathing versus during positive pressure breathing after anesthe-
sia and neuromuscular blockade. Anesthesiology, 97:298–305.
Kroenke K, Lawrence VA, Theroux JF, et al. 1992. Operative risk in 
patients with severe obstructive pulmonary disease. Arch Intern Med, 
152:967–71.International Journal of COPD 2007:2(4) 514
Licker et al
Lanone S, Taille C, Boczkowski J, et al. 2005. Diaphragmatic fatigue during 
sepsis and septic shock. Intensive Care Med, 31:1611–7.
Lawrence VA, Cornell JE, Smetana GW. 2006. Strategies to reduce post-
operative pulmonary complications after noncardiothoracic surgery: 
systematic review for the American College of Physicians. Ann Intern 
Med, 144:596–608.
Lee TH, Marcantonio ER, Mangione CM, et al. 1999. Derivation and 
prospective validation of a simple index for prediction of cardiac risk 
of major noncardiac surgery. Circulation, 100:1043–9.
Licker M, de Perrot M, Spiliopoulos A, et al. 2003. Risk factors for acute 
lung injury after thoracic surgery for lung cancer. Anesth Analg, 
97:1558–65.
Licker M, Khatchatourian G, Schweizer A, et al. 2002. The impact of a 
cardioprotective protocol on the incidence of cardiac complications 
after aortic abdominal surgery. Anesth Analg, 95:1525–33, table of 
contents.
Licker M, Schweizer A, Hohn L, et al. 1997. Unexpected postoperative 
respiratory failure due to diaphragmatic paralysis. Anesthesiology, 
87:1239.
Licker M, Spiliopoulos A, Frey JG, et al. 2001. Management and outcome 
of patients undergoing thoracic surgery in a regional chest medical 
centre. Eur J Anaesthesiol, 18:540–7.
Licker M, Spiliopoulos A, Tschopp JM. 2003. Inﬂ  uence of thoracic epidural 
analgesia on cardiovascular autonomic control after thoracic surgery. 
Br J Anaesth, 91:525–31.
Licker MJ, Widikker I, Robert J, et al. 2006. Operative mortality and 
respiratory complications after lung resection for cancer: impact of 
chronic obstructive pulmonary disease and time trends. Ann Thorac 
Surg, 81:1830–7.
Lindberg P, Gunnarsson L, Tokics L, et al. 1992. Atelectasis and lung 
function in the postoperative period. Acta Anaesthesiol Scand, 
36:546–53.
Liu SS, Block BM, Wu CL. 2004. Effects of perioperative central neuraxial 
analgesia on outcome after coronary artery bypass surgery: a meta-
analysis. Anesthesiology, 101:153–61.
Lysakowski C, Dumont L, Czarnetzki C, et al. 2006. The effect of 
cigarette smoking on the hypnotic efﬁ  cacy of propofol. Anaesthesia, 
61:826–31.
Mackay MR, Ellis E, Johnston C. 2005. Randomised clinical trial of phys-
iotherapy after open abdominal surgery in high risk patients. Aust J 
Physiother, 51:151–9.
Marret E, Kurdi O, Zufferey P, et al. 2005. Effects of nonsteroidal anti-
inﬂ  ammatory drugs on patient-controlled analgesia morphine side 
effects: meta-analysis of randomized controlled trials. Anesthesiology, 
102:1249–60.
McAlister FA, Bertsch K, Man J, et al. 2005. Incidence of and risk factors 
for pulmonary complications after nonthoracic surgery. Am J Respir 
Crit Care Med, 171:514–7.
McAlister FA, Khan NA, Straus SE, et al. 2003. Accuracy of the preopera-
tive assessment in predicting pulmonary risk after nonthoracic surgery. 
Am J Respir Crit Care Med, 167:741–4.
McGory ML, Maggard MA, Ko CY. 2005. A meta-analysis of periop-
erative beta blockade: what is the actual risk reduction?. Surgery, 
138:171–9.
Moller AM, Villebro N, Pedersen T, et al. 2002. Effect of preoperative 
smoking intervention on postoperative complications: a randomised 
clinical trial. Lancet, 359:114–7.
Monk TG, Saini V, Weldon BC, et al. 2005. Anesthetic management and 
one-year mortality after noncardiac surgery. Anesth Analg, 100:4–10.
Moran JL, Bersten AD, Solomon PJ. 2005. Meta-analysis of controlled 
trials of ventilator therapy in acute lung injury and acute respiratory 
distress syndrome: an alternative perspective. Intensive Care Med, 
31:227–35.
Moudgil R, Michelakis ED, Archer SL. 2005. Hypoxic pulmonary vaso-
constriction. J Appl Physiol, 98:390–403.
Nelson R, Edwards S, Tse B. 2005. Prophylactic nasogastric decompression 
after abdominal surgery. Cochrane Database Syst Rev, CD004929.
Nici L, Donner C, Wouters E, et al. 2006. American Thoracic Society/
European Respiratory Society statement on pulmonary rehabilitation. 
Am J Respir Crit Care Med, 173:1390–413.
Nimmo AF, Drummond GB. 1996. Respiratory mechanics after abdominal 
surgery measured with continuous analysis of pressure, ﬂ  ow and volume 
signals. Br J Anaesth, 77:317–26.
Oczenski W, Schwarz S, Fitzgerald RD. 2004. Vital capacity manoeu-
vre in general anaesthesia: useful or useless? Eur J Anaesthesiol, 
21:253–9.
Pansard JL, Mankikian B, Bertrand M, et al. 1993. Effects of thoracic 
extradural block on diaphragmatic electrical activity and contractility 
after upper abdominal surgery. Anesthesiology, 78:63–71.
Paull DE, Updyke GM, Davis CA, et al. 2004. Complications and long-
term survival for alcoholic patients with resectable lung cancer. Am J 
Surg, 188:553–9.
Peterson GN, Domino KB, Caplan RA, et al. 2005. Management of the dif-
ﬁ  cult airway: a closed claims analysis. Anesthesiology, 103:33–9.
Pino RM. 2006. Residual neuromuscular blockade: a persistent clinical 
problem. Int Anesthesiol Clin, 44:77–90.
Polanczyk CA, Marcantonio E, Goldman L, et al. 2001. Impact of age on 
perioperative complications and length of stay in patients undergoing 
noncardiac surgery. Ann Intern Med, 134:637–43.
Polaner DM, Kimball WR, Fratacci MD, et al. 1993. Thoracic epidural 
anesthesia increases diaphragmatic shortening after thoracotomy in 
the awake lamb. Anesthesiology, 79:808–16.
Ram FS, Wellington S, Rowe BH, et al. 2005. Non-invasive positive 
pressure ventilation for treatment of respiratory failure due to 
severe acute exacerbations of asthma. Cochrane Database Syst 
Rev, CD004360.
Ramakrishna G, Sprung J, Ravi BS, et al. 2005. Impact of pulmonary 
hypertension on the outcomes of noncardiac surgery: predictors of 
perioperative morbidity and mortality. J Am Coll Cardiol, 45:1691–9.
Regli A, von Ungern-Sternberg BS, Reber A, et al. 2006. Impact of spinal 
anaesthesia on peri-operative lung volumes in obese and morbidly obese 
female patients. Anaesthesia, 61:215–21.
Reisli R, Apilliogullari S, Reisli I, et al. 2004. The effect of environmental 
tobacco smoke on the dose requirements of rocuronium in children. 
Paediatr Anaesth, 14:247–50.
Rettig HC, Gielen MJ, Boersma E, et al. 2005. Vertical infraclavicular block 
of the brachial plexus: effects on hemidiaphragmatic movement and 
ventilatory function. Reg Anesth Pain Med, 30:529–35.
Rigg JR, Jamrozik K, Myles PS, et al. 2002. Epidural anaesthesia and 
analgesia and outcome of major surgery: a randomised trial. Lancet, 
359:1276–82.
Rocco M, Spadetta G, Morelli A, et al. 2004. A comparative evaluation 
of thermodilution and partial CO2 rebreathing techniques for cardiac 
output assessment in critically ill patients during assisted ventilation. 
Intensive Care Med, 30:82–7.
Rohde LE, Polanczyk CA, Goldman L, et al. 2001. Usefulness of trans-
thoracic echocardiography as a tool for risk stratiﬁ  cation of patients 
undergoing major noncardiac surgery. Am J Cardiol, 87:505–9.
Rooke GA, Choi JH, Bishop MJ. 1997. The effect of isoﬂ  urane, halothane, 
sevoﬂ  urane, and thiopental/nitrous oxide on respiratory system resis-
tance after tracheal intubation. Anesthesiology, 86:1294–9.
Rosenberg J, Rasmussen GI, Wojdemann KR, et al. 1999. Ventilatory pattern 
and associated episodic hypoxaemia in the late postoperative period in 
the general surgical ward. Anaesthesia, 54:323–8.
Rothen HU, Neumann P, Berglund JE, et al. 1999. Dynamics of re-expansion 
of atelectasis during general anaesthesia. Br J Anaesth, 82:551–6.
Rothen HU, Sporre B, Engberg G, et al. 1995. Inﬂ  uence of gas composition 
on recurrence of atelectasis after a reexpansion maneuver during general 
anesthesia. Anesthesiology, 82:832–42.
Rothen HU, Sporre B, Engberg G, et al. 1998. Airway closure, atelectasis and 
gas exchange during general anaesthesia. Br J Anaesth, 81:681–6.
Sakura S, Saito Y, Kosaka Y. 1996. The effects of epidural anesthesia on 
ventilatory response to hypercapnia and hypoxia in elderly patients. 
Anesth Analg, 82:306–11.International Journal of COPD 2007:2(4) 515
COPD and surgery
Salpeter SR, Ormiston TM, Salpeter EE. 2004. Cardiovascular effects of 
beta-agonists in patients with asthma and COPD: a meta-analysis. 
Chest, 125:2309–21.
Schussler O, Alifano M, Dermine H, et al. 2006. Postoperative pneumonia 
after major lung resection. Am J Respir Crit Care Med, 173:1161–9.
Schweizer A, Khatchatourian G, Hohn L, et al. 2002. Opening of a new 
postanesthesia care unit: impact on critical care utilization and compli-
cations following major vascular and thoracic surgery. J Clin Anesth, 
14:486–93.
Silvanus MT, Groeben H, Peters J. 2004. Corticosteroids and inhaled 
salbutamol in patients with reversible airway obstruction markedly 
decrease the incidence of bronchospasm after tracheal intubation. 
Anesthesiology, 100:1052–7.
Sin DD, Wu L, Man SF. 2005. The relationship between reduced lung 
function and cardiovascular mortality: a population-based study and a 
systematic review of the literature. Chest, 127:1952–9.
Smetana GW, Lawrence VA, Cornell JE. 2006. Preoperative pulmonary risk 
stratiﬁ  cation for noncardiothoracic surgery: systematic review for the 
American College of Physicians. Ann Intern Med, 144:581–95.
Spiliopoulos A, de Perrot M. 2000. Four decades of surgery for bronchogenic 
carcinoma in one centre. Eur Respir J, 15:543–6.
Sprung J, Barnas GM, Cheng EY, et al. 1992. Changes in functional residual 
capacity and regional diaphragm lengths after upper abdominal surgery 
in anesthetized dogs. Anesth Analg, 75:977–82.
Squadrone V, Coha M, Cerutti E, et al. 2005. Continuous positive airway 
pressure for treatment of postoperative hypoxemia: a randomized 
controlled trial. Jama, 293:589–95.
Thomas JA, McIntosh JM. 1994. Are incentive spirometry, intermittent 
positive pressure breathing, and deep breathing exercises effective in 
the prevention of postoperative pulmonary complications after upper 
abdominal surgery? A systematic overview and meta-analysis. Phys 
Ther, 74:3–10.
Tirumalasetty J, Grammer LC. 2006. Asthma, surgery, and general anes-
thesia: a review. J Asthma, 43:251–4.
Urmey WF, Gloeggler PJ. 1993. Pulmonary function changes during 
interscalene brachial plexus block: effects of decreasing local anesthetic 
injection volume. Reg Anesth, 18:244–9.
van den Elsen M, Dahan A, DeGoede J, et al. 1995. Inﬂ  uences of subanes-
thetic isoﬂ  urane on ventilatory control in humans. Anesthesiology, 
83:478–90.
van den Elsen M, Sarton E, Teppema L, et al. 1998. Inﬂ  uence of 0.1 mini-
mum alveolar concentration of sevoﬂ  urane, desﬂ  urane and isoﬂ  urane 
on dynamic ventilatory response to hypercapnia in humans. Br J 
Anaesth, 80:174–82.
Vassilakopoulos T, Mastora Z, Katsaounou P, et al. 2000. Contribution 
of pain to inspiratory muscle dysfunction after upper abdominal 
surgery: A randomized controlled trial. Am J Respir Crit Care Med, 
161:1372–5.
Volta CA, Alvisi V, Petrini S, et al. 2005. The effect of volatile anesthetics 
on respiratory system resistance in patients with chronic obstructive 
pulmonary disease. Anesth Analg, 100:348–53.
von Ungern-Sternberg BS, Regli A, Schneider MC, et al. 2004. Effect 
of obesity and site of surgery on perioperative lung volumes. Br J 
Anaesth, 92:202–7.
Warner DO. 2002. Diaphragm function during anesthesia: still crazy after 
all these years. Anesthesiology, 97:295–7.
Warner DO. 2006. Perioperative abstinence from cigarettes: physiologic 
and clinical consequences. Anesthesiology, 104:356–67.
Warner DO, Patten CA, Ames SC, et al. 2004. Smoking behavior and 
perceived stress in cigarette smokers undergoing elective surgery. 
Anesthesiology, 100:1125–37.
Warner DO, Warner MA, Barnes RD, et al. 1996. Perioperative respiratory 
complications in patients with asthma. Anesthesiology, 85:460–7.
Warner MA, Offord KP, Warner ME, et al. 1989. Role of preoperative 
cessation of smoking and other factors in postoperative pulmonary 
complications: a blinded prospective study of coronary artery bypass 
patients. Mayo Clin Proc, 64:609–16.
Whalen F, Sprung J, Burkle CM, et al. 2006. Recent smoking behavior and 
postoperative nausea and vomiting. Anesth Analg, 103:70–5.
Whalen FX, Gajic O, Thompson GB, et al. 2006. The effects of the alveolar 
recruitment maneuver and positive end-expiratory pressure on arte-
rial oxygenation during laparoscopic bariatric surgery. Anesth Analg, 
102:298–305.
Win T, Jackson A, Sharples L, et al. 2005. Cardiopulmonary exercise tests 
and lung cancer surgical outcome. Chest, 127:1159–65.
Wolters U, Wolf T, Stutzer H, et al. 1996. ASA classiﬁ  cation and periop-
erative variables as predictors of postoperative outcome. Br J Anaesth, 
77:217–22.
Yu G, Yang K, Baker AB, et al. 2006. The effect of bi-level positive air-
way pressure mechanical ventilation on gas exchange during general 
anaesthesia. Br J Anaesth, 96:522–32.
Zahid M, Sonel AF, Saba S, et al. 2005. Perioperative risk of noncardiac 
surgery associated with aortic stenosis. Am J Cardiol, 96:436–8.